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Abstract 
 
The pharmaceutical industry is undergoing a transformative shift toward personalized 
medicine and new methods for controlled delivery of those drugs are necessary. MOFs are an 
exciting potential sorbent due to their extremely high surface areas (1,000 m2/g and 10,000 m2/g) 
and ultrafine molecular sieving ability. In this project, we designed, constructed, and validated a 
system and mathematical model for assessing the drug release profiles from porous media. The 
work culminates with a systematic perspective identifying the need for stable, size-tunable 
frameworks that could serve as an excellent and effective drug delivery system. 
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Executive Summary 
 
 Metal-Organic Frameworks (MOFs) are a high surface area, microporous class of crystals, 
which are made up of metal atoms connected by organic chain linkers as can be seen in Figure 1. 
The study of MOFs was derived from the study of zeolites, another high surface area material, 
widely used for catalysis. Recently, MOFs have been studied at length for many applications 
including batteries, substance detection, gas storage, drug delivery, and many more. 
 
Figure 1: Metal-Organic Framework Schematic (Red: metal atoms, Black and White: organic 
linker atoms, Yellow: internal volume) (Boehle)1  
This project attempts to use the internal cage of the MOF to store an active pharmaceutical 
ingredient (API), and investigate the diffusive properties out of the MOF and MOF-like materials 
(zeolites) for use as a drug delivery system. To achieve this goal, an HPLC system was modified 
to achieve an alternate flow through a zero-length continuously stirred tank reactor (CSTR) with 
minimal dead volume. The sorbate used in this project is the common pharmaceutical 
acetaminophen (also known as Tylenol, or paracetamol). The absorbance of the sorbate was 
measured continuously and recorded to be later analyzed with a numerical approach through a 
Matlab model. 
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 The Matlab model was designed to fit a partial differential equation derived by Brandani 
& Ruthven (1995).22 This model had a few parameters which could be modified to fit the data. 
These parameters were L, dead volume, diffusivity constant, pore size, and flow rate. L is a fitting 
variable that condenses a few other variables in the equation derived by Brandani and Ruthven and 
is the ratio of the cell washout time to the diffusion time.22 The model was incentivized to minimize 
the difference between the raw data collected from the HPLC and the generated model with a final 
outcome being the intraparticle diffusion coefficient. 
 As a system validation, common zeolites were also tested (Zeolite HY, and an ion 
exchanged Zeolite-NaY) with the sorbate to obtain desorption profiles to compare to. The results 
from an example run can be seen below in Figure 2. The yellow line shows the model generated 
by the Matlab script, and the blue line shows the raw data form the HPLC. It should be noted that 
beyond 20 minutes, the concentration is so low that it can easily be affected by noise in the detector. 
Therefore, the model was fit by weighting the first 20 minutes more heavily. From this model, it 
could be estimated that the diffusivity constant of 1.4 ∗ 10−13
𝑚2
𝑠
 , and an L “fitting factor” of 
4500. 
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Figure 2: Semi-Log Plot of normalized concentration versus time over-layed with Matlab Model 
of ion exchanged Zeolite-NaY  
 
Due to the nature of the MOF examined in this project, it was not possible to achieve a 
smooth desorption profile.  This paper demonstrates the preliminary data and results about the 
use of MOFs for drug delivery systems. 
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1.0 Introduction 
 
The next generation of pharmaceuticals will take advantage of personalized, protein-based 
medicine. These need to be delivered in creative, controlled ways in order to be viable in the 
pharmaceutical world. Metal organic frameworks (MOFs) are tunable and can potentially offer a 
controlled delivery method.  
Recently, MOFs have been studied for their use in a variety of different settings. MOFs are 
a relatively new crystalline material that have similar properties to their predecessors, zeolites. 
MOFs consist of larger metal ions, interconnected with organic linkers. These combinations of 
metal ions and organic linkers create a crystalline network that allows for a very porous material.  
Both the metal ions and the organic linkers can be changed to create a MOF with different 
properties, making MOFs highly tunable. The length of the organic linker will adjust the size of 
the pores within the MOF. Functional groups on these linkers can also adjust the reactivity and 
functionality of the crystals. Finally, different metal ions will have different bonding orders, 
changing the overall shape of a “unit cell” (smallest single repeating unit) of the framework.  
With a high surface area and extremely tunable properties, MOFs have gathered a lot of 
attention for their possible use in many areas of research. Drug delivery, gaseous carbon capture 
and storage, pesticide detection, anti-corrosion coatings, electrocatalysts for batteries are only just 
a few of the possible applications for MOFs in current research.2 
This paper studies the diffusivity properties of one particular MOF, known as IRMOF-1 
(also known as MOF-5), using a common over-the-counter pharmaceutical (Acetaminophen, also 
known as paracetamol). A diagram of IRMOF-1 can be seen in Figure 1. 
Nanocarriers of any kind for use in drug delivery need to meet a few requirements to be 
efficient and worthwhile. These nanocarriers must (1) efficiently encapsulate the drugs with high 
 12 
payloads, (2) control the drug’s release without over or under delivery, (3) control the matrix 
degradation, (4) offer the capability of engineering the surface of the carrier, and (5) be detectable 
by conventional imaging techniques. 
Some current materials being used for drug delivery include liposomes, nanoemulsions, 
nanoparticles or micelles. All of these materials work to some degree, but they are unsatisfactory 
in some regards. Therefore, better routes to drug delivery are necessary to overcome their 
limitations. With their extremely tunable properties, MOFs seem to be a good candidate for an 
improved drug delivery route.3 
In this paper, to study one aspect of the drug delivery capability of IRMOF-1, the diffusive 
properties of paracetamol through the pores of the MOF was studied, analyzed, and modeled. 
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2.0 Literature Review 
2.1 Diffusivity 
 
Diffusion occurs in all gas, liquid, and solid mixtures. This molecular motion occurs due 
to concentration gradients in a system that push the system to move toward equilibrium. Diffusion 
rates are typically described by a molar or mass flux which is the amount of a particular species 
through a cross sectional area that is normal to the vector it is traveling along. The flux of a species 
is described by its concentration gradient and diffusion coefficient that is with respect to the species 
that it is diffusing through and the concentration gradient. This relationship is known as Fickian 
diffusion, which is represented by the equation: 
  
 𝐽𝐴,𝑧 = −𝐷𝐴𝐵
𝑑𝐶𝐴
𝑑𝑧
  (1) 
    
This form of the equation applies to a homogeneous system. The diffusion coefficient is a 
function of the pressure, temperature and composition of the system. Typically, diffusion 
coefficients are highest for gases and lowest for solids.  
While diffusion in gas systems can be simplified fairly well due to the lack of interaction 
between molecules, liquid mass diffusion is a more complex system. In a liquid, molecules are 
tightly packed together meaning that concentration gradients can result in changes in viscosities 
which leads to a change in the ideality of the system (i.e. molecular interactions cannot be 
neglected). Two theories have been proposed to deal with these complexities. The Eyring “hole” 
theory assumes that the solvent atoms form a quasi-crystalline shell around a diffusing molecule 
with periodic holes in the lattice where solute atoms jump from vacancy to vacancy. The 
hydrodynamical theory states that the liquid diffusion coefficient is related to the solute mobility 
through the solvent. The solute’s molecular mobility is represented by the net velocity of the 
 14 
molecules under the influence of a driving force. The result of combining both theories results in 
an equation where the diffusion coefficient is dependent on temperature and the viscosity of the 
solvent. Several correlations have been developed to describe certain isolated cases. An example 
of this is the Wilke-Chang relationship. This correlation applies to nonelectrolytes in an infinitely 
dilute solution and defines the diffusion coefficient as a function of the temperature, viscosity of 
the solvent, “association” parameter and molar mass of the solvent, and the molal volume of the 
solute at normal boiling point.  
As mentioned before, even though liquid mass diffusion can be extremely slow, diffusion 
into and through a solid is much slower. This is effect is shown by the table of known values of 
diffusion through various mediums shown below: 
Table 1: Comparison of diffusivities; gas-in-gas, liquid-in-liquid, and solid-in-solid4 
Phase Diffusivity Coefficient Range 
Gases 5.6 ∗ 10−6 to 10−5
𝑚2
𝑠
 
Liquids 10−10 to 10−9
𝑚2
𝑠
 
Solids 5.6 ∗ 10−14 to 10−10
𝑚2
𝑠
 
 
In particular, pore diffusion, a type of solid diffusion, is a crucial parameter for applications 
such as catalytic reactors and adsorption processes. Pore diffusion itself is divided into three 
categories of pore diffusion: Bulk diffusion, Knudsen diffusion, and surface migration. Bulk 
diffusion involves the diffusion of gas or liquid molecules through macropores (> 50 nm). Knudsen 
diffusion applies to the diffusion of gases through large cylindrical pores called mesopores (2-50 
nm), which is of interest when considering the use of MOFs for safe storage of hydrogen to be 
later used in a fuel cell. Surface migration applies to micropores (< 2 nm) that is a representation 
of what occurs in diffusion of a solute through a bulk solid.5 
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Hindered solute diffusion in solvent-filled pores applies when a solute in a liquid solution 
is diffusing into tiny capillary pores (50 to 200 Å)6 in a porous material. It is called this due to the 
hinderance provided by the pores themselves and the pore walls. The diffusion coefficient that 
describes this model is a function of the diffusion coefficient of the solute in an infinitely dilute 
solution and two reducing correction factors. Each correction factor is a function of the reduced 
pore diameter which is a ratio of the solute molecular diameter and the free pore diameter. These 
correction factors are bound by the principle that if the molecule was larger than the pore then it 
will not diffuse into it. This is ensured because as the reduced pore reaches one, the correction 
factors approach zero resulting in a diffusion coefficient of zero. The first correction factor is 
known as the steric partition coefficient which is based on geometric considerations of the solute 
particle trying to diffuse and is described by the equation: 
 𝐹1(𝜙) = (1 − 𝜙)
2 (2) 
 
The second correction factor is known as the hydrodynamic hindrance factor which is 
based on hindered Brownian motion of the solute within the pore and is described by the equation: 
  
 𝐹2(𝜙) = 1 − 2.104𝜙 + 2.09𝜙
3 − 0.95𝜙5 (3) 
 
The other major type of solid diffusion involves diffusion into a bulk solid. This type of 
diffusion is more commonly known and is prominent in many processing techniques such as 
carburizing and nitriding. Solid-solid diffusion, within the bulk, is also what causes segregation of 
metal ions within a material which can lead to failure of a part such as when chromium diffuses to 
the surface of a steel and is all used up when it oxidizes at the surface and thus cannot be used any 
longer to protect the steel.5 
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2.2 Residence Time Model 
 
Residence Time of a system is the amount of time that a single molecule of sorbent lingers 
in a reactor system before being purged. The residence time distribution (RTD) is the profile of a 
molecule leaving the system with the amount of time that a molecule can spend inside.7 Residence 
time is needed in order to understand the mixing within reactors to determine how the real reactor 
that is being used compares to an ideal model. Often the RTD model can help to determine 
individual reactor models which can then be placed in series.8 Using reactors in series can help to 
obtain the desired yield, size, and timescale. Overall the RTD can help to construct future reactors 
and understand any problems in the ones currently being used. 
Different reactor types have different models for RTD. Continuous Stirred Tank Reactors 
(CSTR) and Plug Flow Reactors (PFR) are typical reactors that are used. CSTR reactors are unique 
because their concentration gradient of a species is the same both in and out of the actual reactor.8 
PFR reactors are slower but are much more efficient at converting all of the reactants as all species 
are converted before actually continuing in the system. Sizing becomes an issue with using only 
PFR reactors and a combination of them typically leads to a more ideal system based on both 
timescale and size.9 PFR reactors have no mixing within them while CSTR reactors are typically 
assumed to be well mixed which means that it can be continuously run if complete conversion is 
not required or if the reaction is significantly spontaneous and quick.8 The flow in the reactors 
have different dispersion models which dictate the residence time in the system. PFR reactors have 
no axial dispersion and are restricted in one direction until the yield is achieved and the products 
are released downstream.7 CSTR has axial dispersion as it is mixed and leads to a residence time 
that follows an exponential decay.8 Figure 3 shows the difference in the models. 
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Figure 3: Concentrations using impulse input into PFR (a) and CSTR (b)8 
The equations for finding the RTD are based on two different models. The Cumulative 
Distribution Function F(t) and the RTD Function E(t). The cumulative distribution function is the 
model of the molecules that are exiting the reactor and have spent time in the reactor. The 
derivative of this function finds the RTD Function E(t) which is the amount of molecules that have 
spent a range or distribution of time in the reactor. The reason for using one or the other is 
determined based on the experiment that is chosen for finding the resonance time. The two options 
are pulse injection or the step method. Equations (4) and (5) are the RTD Function Equations for 
PFR and CSTR.8 
  
 𝐸(𝑡) = 𝜎(𝑡   𝜏) (4) 
  
 𝐸(𝑡) =
1
𝜏
𝑒−
𝑡
𝜏 (5) 
The RTD of PFR and CSTR reactors can be found by using one of two methods. A pulse 
injection can be used to directly determine the E(t) equation which has benefits in losing error in 
taking the derivative of F(t).7 It is useful if the material is expensive and a pure stream cannot be 
used through the system. Steps have an abrupt change from a concentration of zero to a maximum 
concentration. The step method is easier to perform but is more difficult to model E(t) based on 
the results. Figure 4 shows the method and the responses for both pulse and step injections.8 
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Figure 4: The Methods of Pulse and Step Injections and their Responses8 
        A benefit of the modeling of RTD is the diagnosing of dead volume in a system. When 
conducting experiments, the dead volume can lead to inefficiencies and can lead to holdup in the 
release of all species in the system. In order to know how much is in the system, residence time 
(𝜏) is equated to the dead volume over the volumetric flow rate. 
 𝜏 =
𝑉
𝑣𝑜
 (6) 
 
        By finding this, a systematic removing of pieces of the system can be conducted in order 
to reduce the dead volume to an acceptable value for the experiment. In a cell that was used in one 
experiment, multiple steps with different flow rates were taken using a high-performance liquid 
chromatography machine.10 By finding the residence time at each flow rate and plotting versus the 
inverse flow rate, the dead volume of the system can be found.11 RTD is used in this project to 
optimize the high-performance liquid chromatography system to reduce its effect on desorption 
profiles in a reactor bed. The desorption profile tends to be affected by washout time in the short-
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time profile and a reduced dead volume means that the system does not need to run longer times, 
thus saving time and material. 
 
2.3 High Performance Liquid Chromatography (HPLC) System and Uses 
 
A high-performance liquid chromatography (HPLC) is a machine designed for the flowing 
of liquids at a specific flow rate through different flow modules until it ultimately reaches a diode 
array detector (DAD) that is used for sampling. The typical setup involves the two binary pumps 
that pipe to a degasser for pure liquid solutions and no gas that can damage the detector. These 
binary pumps then connect to two mixing points to ensure that the flow is consistent and well 
mixed, which allows for a removal of any previous contaminants. From the mixing point, the flow 
travels to an injector port where sorbate can be added by an automated micro-injector or in the use 
of step methods. The injector port is important for insertion of pulse slugs that can be characterized 
through a column or could be used to find residence times in a reactor. From here the flow goes to 
another six-port valve that can send the flow through a column. From here it goes to the DAD and 
is purged out of the system to waste.12 
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Figure 5: HPLC Setup 
The HPLC’s use of columns is the main advantage to using an HPLC. The columns can be 
used to separate an unknown mixture from an injected pulse or a flow from a large amount of 
liquid.13 Different types of columns can be inserted, but the typical system has a column packed 
with resin that chromatographically separates the components into different fluid slugs that then 
travel at different points through the detector and a range of wavelengths can be used to determine 
the flow’s composition.14 The high pressure in the system is needed to force the slugs through the 
column and differentiates the system from a regular liquid chromatography what simply looks at 
single species sorbates. Figure 6 shows the basic setup for an HPLC system. 
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Figure 6: HPLC schematic showing how a solvent reservoir gets pumped through a high pressure 
pump to sweep the sample injection through an HPLC tube to the UV detector. 15 
The system is often compared to gas chromatography (GC) due to their use in separations 
and characterizations. While GCs use an inert carrier which does not differ very much between 
different samples, HPLCs need specific solvents in order to run between different solutions. 
Sometimes water would be needed for inorganics and an alcohol might be needed for organics. 
The type of columns also makes a large difference. In HPLCs, a tight packed column must be used 
while the GC can use capillary columns or tight packed ones.16 Capillary columns typically have 
better resolution of separations. Ultimately the choice between the two machines comes from the 
use of volatile mixtures that are flowed as the sorbate. HPLC needs a liquid mobile phase.17 The 
use of liquids offers a better way to understand solutions than trying to gasify all components for 
use in a GC. In the system analyzed in this report, the analyte is paracetamol, which is non-volatile, 
so HPLC was the ideal mechanism for data collection. 
The DAD in HPLC systems typically have a tungsten lamp that emits visible light which 
goes through a deuterium lamp to add more wavelengths of light along with some portions of the 
UV spectrum.18 The light passes through a slit and onto a diffraction grating to split the light into 
various wavelengths. Another slit enables the desired specific wavelengths to pass through and 
 22 
this grating is moved depending on what is needed.18 The light then passes through a flow cell and 
then through a photodetector after going through the fluid and the difference in the amount of light 
supplied and received is measured in absorbance units (AU).12 Figure 7 shows the process. 
 
Figure 7: Diode Array Detector Schematic. Light from the lamps travel through a slit to be 
diffracted into a slit that can be moved depending on the wavelength needed. This beam is then 
split for a reference and allowed to go through the flow cell to another detector that shows the 
resulting intensity.19 
2.4 Zero-Length Column Modeling 
 
Zero Length Column (ZLC) analysis is used to determine the adsorption and desorption 
characteristics of certain materials. ZLC is typically used for gas phase, but the same concept 
applies to liquid phase (with minor mathematical model adjustments). A basic ZLC apparatus 
includes two feed streams (one pure solvent, and one with a known concentration of 
sorbate/analyte). These two feeds enter a valve that can switch between them. The valve pipes to 
a column of “zero-length”, or a very small length, which allows for the assumption of a well-mixed 
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cell. The ZLC is packed with a very thin (1 particle thick) fixed bed of sorbent. A general process 
of the ZLC can be seen below in Figure 8. 
 
Figure 8: Basic ZLC Apparatus showing all general parts and basic flow pattern.  20 
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Figure 9: Image A shows the ZLC Column used in this project with 1/16th inch tubing going to a 
1/8th expander which is fit to the chamber at the two frits. This is then reduced on the other side 
downstream. Image B shows the ZLC model and all parts were purchased from Vici Valco. 
The Péclet number (Pe) is the ratio of the advective transport rate to the diffusive transport 
rate (Lu/D), which also describes the axial mixing within a packed column (a larger Pe means 
better axial mixing). With this definition, as the length, L, approaches 0, Pe approaches infinity. 
In gas phase ZLC, a small sample of absorbent is brought to equilibrium with a sorbate at a known 
partial pressure. After the column, the effluent flows through a detector that reads the concentration 
of the sorbate. The sorbate is transported by an inert gas, typically helium. At the start of the 
experiment, the feed to the column is switched by the valve from the pure carrier stream to the 
stream with a known partial pressure of the sorbate in the carrier. The detector produces a response 
A 
B 
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curve in terms of the concentration of the sorbate over time. Changing system components like 
pressure, temperature, flow rates, etc. will elicit different response curves. 
 
Ruthven & Stapleton used a ZLC to model the desorption characteristics of Zeolite-NaX. 
In this paper, it was determined that the ZLC was dependent on following the transient desorption 
curve with a small amount of the zeolite crystal packed in the column. The system in this 
experiment consisted of benzene (sorbate) in hexane. Initially, the zeolite was saturated with the 
sorbate. Once saturation of the zeolite was achieved, the flow was switched to pure hexane at a 
relatively high flow, effectively removing the sorbate.  
 
Figure 10: Full uptake, saturation, and desorption profiles 
The desorption rate was controlled by the internal diffusion of the crystal. Therefore, the 
external concentration of the crystal must remain at zero, which necessitated the aforementioned 
 26 
relatively high flow rate. Although this process of liquid phase ZLC is very similar to the 
equivalent gas phase, mathematical modeling of the liquid phase becomes more involved.21 
 
 
2.5 Mathematical Model 
 
 Brandani and Ruthven wrote many papers that were useful in the mathematical modelling 
of the desorption curve for a ZLC with liquid systems. The paper describes an approach to 
experimental data in regards to a binary liquid system through a zeolite absorber. The model is 
based on an analytical method that is controlled by intraparticle diffusion. This means that the 
model takes into account the time constant for diffusion between the sorbent and the washout time 
for the desorption of the sorbent. The derivation of the model begins with two mass balances, one 
on the fluid phase of the flow and one on the solid phase. The solid material (phase) is typically a 
zeolite. When time is zero, the initial concentration is defined by a constant. The boundary 
conditions are defined at the center of the particle and at the surface of the particle for the solid 
phase mass balance. The solid phase balance is then inserted into the fluid phase balance to 
simplify the equation. Through changing variables like diffusivity and noting that there will be a 
finite amount of adsorbed paracetamol at the surface of the particle, the correct boundary condition 
at the surface is determined to be non-zero and can be solved for numerically. Equation (7) through 
(13) shows the important equations in used in the process of solving the mass balances.22  
Governing Equations: 
Fluid-phase mass balance: 
 𝑉𝑠
𝑑𝑞
𝑑𝑡
+ 𝑉𝑓
𝑑𝑐
𝑑𝑡
+ 𝐹𝑐 = 0 (7) 
Solid-phase mass balance: 
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 ∂q
 ∂t
= 𝐷(
 ∂2𝑞
𝑑𝑟2
+
2
𝑟
 ∂q
 ∂r
) (8) 
Initial Conditions: 
 𝑞(𝑟, 0) = 𝑞0𝐾𝑐0;    𝑐(0) = 𝑐0 (9) 
Boundary Condition: 
 (
 ∂q
 ∂r
)
𝑟=0
= 0 (10) 
Equation (7) can be considered as a boundary condition on the solid-phase mass balance 
(Equation (8)) 
 
4
3
𝜋𝑅3
 d?̅?
 dt
= 4𝜋𝑅2𝐷 (
 ∂q
 ∂r
)
𝑟=𝑅
 (11) 
With equilibrium at the surface; 
 𝑞(𝑅, 𝑡) = 𝐾𝑐(𝑡) (12) 
 Separation of variables allows for the equation to be solved. The paper further simplifies 
beyond what is needed for a liquid system that is present in our methods. The gamma term that 
was set to zero cannot be zero in this case, due to the fluid being a liquid rather than a gas. This 
adjusts for liquid holdup in the system. In the creation of desorption curves, the long time is needed 
to ensure that the exponential decay will reach the 
𝑅2
𝛽1
2𝐷
 as the washout process is still going on. 
Equation (13) shows the concentration over shorter times and the tuning of L and gamma to be 
able to obtain the value of Vf and the diffusional time constant. These are obtained using the slope 
and intercept of the long-time asymptote with the graph of the short time.22  
 
𝑐
𝑐𝑜
≃ 1 −
𝐿𝐷
𝛾𝑅2
𝑡 ≃ exp (−
𝐹
𝑉𝑓
𝑡) 
(13) 
 
 
A numerical solution, created in Matlab, solves Equation (8) as a boundary value problem 
using initial and boundary conditions defined in Equations (9), (7) and (10) respectively. The outer 
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boundary condition at the outer radius of the particle is solved for as a function of flow rate using 
Equation (7). The diffusivity value was estimated until the resulting desorption profiles fit the 
HPLC data, with emphasis on fitting the long-time desorption region.  
The analytical solution was derived by Ruthven and Brandini as well.22 This solution is 
based on gas phase in a ZLC. It makes several assumptions that are not valid for this project’s 
system because it is liquid phase in a ZLC and the holdup term that is not used in the assumption 
would be required in this situation.  
 
2.6 Zeolites 
 
Zeolites are porous crystalline materials with large specific surface areas.23,24 Typically 
composed of networks of aluminum and silicon tetrahedrally bonded to oxygen atoms (Al2O3 and 
Si2O4) that are connected by corner oxygen atoms, zeolites have a cage-like structure with many 
micropores. Zeolites may also contain positive cations, like sodium or potassium to balance out 
negative charges within the structure.25 Pore sizes of zeolites tend to be between 0.3 nm and 2 nm. 
Due to the continuous microporous structure and high specific surface area of these materials, 
zeolites find uses in many different areas such as carbon dioxide capture26, catalysis27, and ion 
exchange28.  
While a great supply zeolites exist in the natural world, many types are not suitable for 
many applications due to structural defects and chemical impurities.23 Rather, synthetic zeolites 
are more commonly used when precision of structure is critical. These zeolites are more pure and 
have a structure more uniform than that of natural zeolites, and differences in temperature, 
pressure, reagent concentration, pH, and reaction period can be manipulated to form different kinds 
of zeolites.25 These different kinds of zeolites are classified by the ratio of alumina to silica in their 
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structures. Low silica zeolites like Na-X have molar ratios of Si/Al less than 2. Intermediate silica 
zeolites like Na-Y have Si/Al ratios between 2 and 5, and high silica content zeolites like ZSM-5 
have Si/Al ratios greater than 5.29  
 
 
Figure 11: Different Cage Geometries of Various Zeolites. These different cage shapes result in 
different overall network structure with different pore sizes30 
 
2.7 Metal Organic Frameworks (MOFs) 
 2.7.1 Characteristics 
 
Much like zeolites, Metal Organic Frameworks (MOFs) are 3 dimensional microporous 
structures that have a uniform structure and high specific surface areas typically between 1,000 
m2/g and 10,000 m2/g. 2,31 Unlike zeolites, which are composed largely of silica and alumina 
tetrahedrally bonded to oxygen atoms, MOFs are built from organic ligands bonded to metal ion 
clusters. These clusters are the secondary building units (SBUs) of the MOF and are one of the 
main differences between zeolites and MOFs.32 These SBUs are important for stability of the MOF 
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and create permanent porosity. The connecting units between the metal clusters are organic 
ligands. Together with the SBUs, these ligands form rigid geometries like squares and octahedra 
that provide structural stability throughout the material.31 These ligands are typically carboxylates, 
but tetrazolate and sulfonates can be used during MOF synthesis as well allowing for many of the 
chemical properties and physical pore dimensions to be highly tunable. This tunability allows for 
MOFs to have a range of pore sizes from several angstroms for microporous MOFs to nanometers 
for mesoporous MOFs. 
 
 
Figure 12: Basic MOF Structure (Red – metal atoms, Black – organic linker, Yellow – internal 
volume)33 
 
In Figure 12 above, the red dots represent metal ions and the black dots represent organic 
linker molecules. The yellow space is the unoccupied volume inside the MOF pore, which is the 
space inside the cage created by the SBUs and organic linkers.  The relative size of yellow space 
compared to the ion clusters and linkers shows how large the pores are compared to the materials 
they are composed of.  
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MOFs have very high specific surface area due to their high porosity (typically higher than 
50% of the total volume)31, making them suitable in many different applications like catalysis, gas 
capture, and drug delivery. This high surface results in a large amount of space for adsorption to 
the MOFs surface. The amount of material that can be stored per a certain mass or volume is an 
important factor in drug delivery, gas storage, and capture. For example, CO2 capture is a technique 
used to reduce greenhouse gas emissions to the atmosphere from industrial processes. CO2 adsorbs 
to the surface of the MOF, preventing it from being released into the atmosphere. Getting the most 
CO2 captured per unit mass or volume is critical to reducing emissions and maximizing capture 
due to restraints of the operational equipment, and MOFs are suitable materials for the job. MOFs 
MIL-101 and MOF-107 have great potential in these applications because they have been found 
to capture 40 mmol of CO2 per gram of MOF and 33.5 mmol of CO2 per gram of MOF, 
respectively.2 MgMOF-74 also shows great potential as a CO2 capture material. Compared to other 
high surface area materials like zeolites, MgMOF-74 was able to capture more than twice as much 
CO2 as other MOFs and zeolites tested.34  
The high adsorption capacity of MOFs is also important in drug delivery since more of a 
drug can be contained in a smaller space. Additionally, the materials MOFs are composed of are 
non-harmful and the linkers can be chosen so that they are biodegradable and minimize harmful 
side effects to the body. 
2.7.2 History of MOFs 
  
The many applications of porous materials like zeolites has been the focus of many 
different fields since the 1800s. However, the materials that they are composed of as well as the 
chemical techniques that are used to synthesize zeolites limit the control over the final zeolite 
structure. This limitation led to great interest in finding a method to create fully controllable and 
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tunable microporous structures and materials that could be used in similar applications as zeolites. 
The result of this research was the synthesis of MOFs. The first MOFs appeared in the early 1990s, 
with the term MOF being used for the first time in 1995.35 
The first significant early MOFs were reported in two publications in 1999. Ian Williams 
published an article on HKUST-1 MOF in March of 1999, while Yaghi published on MOF-5 in 
November.35 These were two of the first publications to mention highly porous MOFs with large 
specific surface areas. In particular, MOF-5 showed higher specific surface area than most zeolites. 
Since the explosion of MOF research in the 1990s, more than 20,000 types of  MOFs have been 
synthesized.31 One of the most important discoveries in the last couple of decades involves the 
structure of MOFs and how they differ from other coordination structures. Many coordination 
compounds were composed of organic linkers such as 4,4-bipyridine connected by metal ions. 
Eventually, coordination compounds created in this way suffer from a collapse of structure and 
destruction of the pore. The discovery that using multidentate linkers like carboxylates allow metal 
ions to create M-O-C clusters was significant in creating MOF structures with permanent 
porosity.32 Figure 13 shows the difference between a coordination compound made of an N-bound 
polytopic organic linker like 4,4-bipyridine and one with secondary building units. 
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Figure 13: Older coordination compound (a) vs MOF structure with SBUs (b)32  
These SBUs lead to a more stable structure with in turn leads to permanent porosity, or 
pores that do not break down as a result of broken structure. Permanent porosity was a desirable 
property poised by zeolites that was now able to be synthesized in synthetic MOFs. 
 The synthesis of higher surface area MOFs has been difficult due to the fact that multiple 
frameworks that became intertwined seemed to form when using longer organic linkers (longer 
organic linkers are required for ultrapourous MOFs).31 This problem was solved by selecting 
certain linkers that prohibited the construction of multiple internal frameworks by using materials 
that create MOFs that would have to form a different topology in order to create interpenetration. 
In 2004, this approach yielded the highest surface area MOF ever created with 3780 m2/g, and 
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within 6 years that milestone was nearly doubled in 2010 when a MOF with 6240 m2/g and 90% 
porosity was synthesized.31  
 2.7.3 MOF Synthesis 
The basic MOF synthesis materials consist of the metal in salt form, the organic linker 
molecule, and a solvent for the crystallization to take place in. The metals are typically zinc or 
copper salts. The organic linker molecules have carboxylic acid groups on either end to serve as a 
bonding site to the metal ion. The solvent used in the crystallization process is a formamide solvent, 
typically dimethylformamide or diethylformamide. 
The classical solvothermal synthesis involves mixing the metal salt with the organic linker 
in a stable solvent. This solution is put into a pressure bomb and heated to catalyze the 
crystallization process. Once the crystallization is completed, the reaction is quenched in room 
temperature water and the crystals are extracted. The advantage of this process is the simplistic 
equipment. One disadvantage is the lack of repeatability.   
While MOFs are typically synthesized solvothermally, there are studies that show more 
reliable, and stronger yield syntheses. One synthesis method that has been studied more recently 
is the use of ultrasonic irradiation. Ultrasonic irradiation can lead to homogeneous nucleation. This 
would be desirable if the product required needed to be uniform in structure. Another main 
difference between ultrasonication and other methods of synthesis is the acoustic cavitation 
phenomenon. This is the creation, growth, and collapse of a bubble in a liquid medium. This 
phenomenon leads to extremely high localized temperatures, on the order of 2000K - 5000K, very 
high cooling rates, and shockwaves created by the homogenous cavitation. This dramatically 
changes the surface morphology, composition, and reaction rate of the then produced crystal. 
Another crystal synthesis route is microwave radiation. Microwave radiation is much more 
commonly used in large scale production and produces a more desirable crystal due to the direct 
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and uniform energy of the microwave system. Microwave radiation also leads to homogeneous 
nucleation like ultrasonication, and also leads to fast crystallization, diverse morphology and size, 
phase selectivity, and particle size. 
With the vast difference in types of MOFs and their respective syntheses, characterization 
methods are required to compare the crystals. Some of these characterization techniques include 
x-ray diffraction, fourier-transform infrared spectroscopy, thermogravimetric analysis, and 
Brunauer-Emmett-Teller analysis.2 
2.7.4 IRMOFs 
A widely studied class of MOF is that of isoreticular MOFs (IRMOFs). IRMOFs share a 
common cubic structure, with zinc vertices connected by organic linkers. These MOFs can be 
synthesized in many different ways, but most commonly they are synthesized in a solvothermal 
procedure, where a zinc salt and the organic linker are dissolved in a formamide solvent.2 
 2.7.5 MOF Imaging 
Nanoscale MOFs (NMOFs) can serve as molecular imaging probes. One type of imaging 
these compounds can be applied in is optical imaging. This type of imaging is common during 
surgeries and allows for great improvement in the outcome of the surgery. Currently, conventional 
fluorophores and quantum dots are utilized for this application. Inherently luminescent NMOFs 
don’t make the cut when it comes to the required absorption and quantum yields needed to 
effectively image something like an organ or tissue. For this reason, many of these NMOFs are 
functionalized with various dyes to improve these yields. Rowe et al. prepared Gd(III) NMOFs 
that were functionalized with polymer chains that contained fluorescein. These NMOFs were used 
to target cancer cells and the showed specific location of these cells after 1 hour of incubation and 
24 hours of internalization. Another group developed Gd(III) NMOF particles where the organic 
linker was functionalized with perylene-3,4,9,10-tetracarboxylate, which is an anionic dye. Both, 
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in vitro and in vivo experiments revealed good biocompatibility and accumulation of the NMOF 
in the liver. Lin et al. functionalized an Fe-based NMOF with a Bodipy-based fluorophore which 
was not fluorescent due to iron quenching. However, it was fluorescent when the MOF began to 
break down. 
Even though optical imaging can provide excellent resolution, the natural luminescence of 
tissue and ingested compounds can make it difficult to quantify the fluorescence signals that are 
being provided by the NMOF. Also, the penetration depth is limited. These drawbacks can be 
limited though by optimizing the combination of mode of imaging and contrasting agent. Also, 
regardless of these drawbacks, this type of imaging is fast and optimal for high-throughput 
screening meaning that it can be used for vitro cell labeling.  
Another type of imaging where these NMOF systems can be utilized is magnetic resonance 
imaging (MRI). This technique is a noninvasive diagnostic method for providing high quality 
images of internal structures of the body. The contrast that is developed by MRI is a result of 
differences in the relaxation rate between tissue water photons. This contrast can be greatly 
improved by using a contrasting agent which essentially decreases the relaxation rate of the 
photons. The effectiveness of the scan depends on the positive and negative enhancement. Based 
on the positive and negative enhancement signals acquired, contrasting agents are categorized 
under T1 or T2 binary types. Currently available T1 contrasting agents include Gd-related 
complexes due to their paramagnetic properties. Currently available T2 contrasting agents are 
mostly nanoparticles which include superparamagnetic iron oxide. Recent research has looked to 
use NMOFs for the purpose of carrying large amounts of paramagnetic ions. Lin et al. created 
NMOFs that incorporated Gd3+ ions into the center of each which demonstrated exceptionally large 
positive and negative enhancement since there was such a large concentration of Gd3+ ions.36  
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2.8 MOF Applications 
 2.8.1 Drug Delivery 
Chemotherapy is the still the most common treatment method for cancer. Chemotherapy 
brings upon negative side effects and a low chance of succession for certain cancers. Traditional 
direct drug administration is not as effective either as this mode causes negative side effects and 
poor drug distribution in the body. Some newer technologies include liposomes, nanoemulsions, 
nanoparticles and micelles which allow more directed drug delivery. However, these compounds 
suffer from low loading capacities and porous inorganic compounds themselves have undesirable 
toxicity and degradability once inside the body.  
Drug carriers in general require these properties: 
• Hold a high “payload” 
• Controlled release without demonstrating the “burst effect” 
• Control the degradation of the matrix 
• Easily engineer surface in order to control en vivo fate 
• Characterize by imaging techniques 
 MOFs provide an excellent match to the required properties. The advantages of using 
MOFs for drug delivery is due to their structure, morphology, composition, pore size, and chemical 
properties can be manipulated to allow for stimuli-controlled drug release and functionality. 
MOFs’ high surface area allowing for them to have high “storage” capacity. Lastly, the presences 
of organic linkers allow for them to be easily biodegradable within the body.3  
Férey et al. developed two chromium-based MOFs to study the desorption kinetics of IBU, 
a non-inflammatory drug, to see if the use of these MOFs would be suitable for the delivery of this 
drug. However, chromium is known for its toxicity to the human body so Fe-based MOFs were 
developed as well.37 The iron-based MOFs reported a 21-day total release time for IBU when 
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tested in a simulated body fluid at 37℃. These MOFs also showcased an ability to adapt their pore 
size to the size of the molecule to maximize the drug-matrix interactions. The Fe-based MOFs 
were also tested with other drugs such as the antitumor drug DOX and antiviral drugs CDV and 
AZT-TP where they continued to show high loading capacities for these drugs.3  
Zn-based MOFs were also being tested as nanocarriers for the anticancer drug 5-Fu and 
the antitumor drug RAPTA-C. The Zn-based MOF utilized for delivery of 5-Fu showed a total 
release time of 7 days. Figure 14 shows this release data collected by C. Sun et al., but mechanisms 
for release nor manipulation of pore size was not tested in this study.38  
 
Figure 14: 5-Fu Release Profile for a Zn-Based MOF38 
A second group, S. Rojas et al., prepared a second type of Zn-based MOF that had four 
different derivations. These derivations utilized four different side groups (-OH, NH2, H, and NO2) 
on the organic linker to see how the side group affected the release profile. These MOFs showed 
release times in between 49 to 80 days as partially shown in Figure 15. However, there was an 
initial burst release observed for all four MOFs. It is summarized that the -OH derivative MOF 
shows higher delivery rate due to possible degradation of the MOF matrix. The -NH2 derivative 
 39 
shows a slower release but still it is high and this may be due to the polarity induced by the side 
group causing the MOF to essentially hold onto the RAPTA-C molecule more strongly as well as 
having a smaller pore volume than the other MOFs. The step delivery profile is possibly due to 
matrix flexibility. The -H and -NO2 derivatives show controlled, slow, and linear release profiles 
and this may be due to high loading capacity of the -H derivative and small polarity exhibited by 
the two side groups.39 
 
Figure 15: RAPTA-C Release Profiles for Four ZnBDP MOFs39 
Zr-based MOFs are of special interest in the use of drug delivery due to their two octahedral 
and tetrahedral cages, high stability, and non-toxicity. Lin et al. studied the use a Zr-based MOF 
for the encapsulation and coordination of a cisplatin prodrug and siRNA. This resulted in the 
apoptosis of the targeted cells in the experiment meaning that this co-delivery method would 
improve the effectiveness of the chemotherapeutic effects of cisplatin in vitro. 
Some MOFs are also stimuli responsive. One such stimuli that promotes drug release is 
pH. An example of this was an Fe-based MOF in which a layer of silica was deposited on the 
surface of the MOF. The MOF, independent of the coating, readily released the drug upon entering 
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an environment with a low pH. To allow for a slower release, the silica coating was applied to the 
MOF. A second response is a magnetical response. A common material that MOFs are being 
composed of for this task is magnetite (Fe3O4). The interesting part about this type of response is 
that these MOFs can be magnetically guided to the site of the tumor to allow for more effective 
therapeutic results. A third type of stimuli-responsive MOF is one that is sensitive to small changes 
in the physiological temperature of the human body. One example of this involves using PNIPAM 
as a building block in the MOF. This is because PNIPAM has a cloud point around 32℃ and thus 
when the temperature of the system the MOF resides in goes below this temperature, PNIPAM 
because hydrophilic and will dissolve in water, but, in the process, will also form an aggregate. 
This dissolution in water allows for drug release and so sicknesses that cause variations in the 
temperature of the body will cause release of the drug until the temperature stabilizes. 
Since the human body is a complex organism, using MOFs with a single stimuli response 
may not be sufficient. To address this issue, the development of multiple-stimuli-responsive MOFs 
is being carried out to further increase the precision and efficacy of drug delivery. One 
supramolecular host that is quickly becoming applicable for this task is a pillararene. Pillararenes 
possess a special structure that allows for excellent host-guest performance and versatile 
functionalization. Pillararene-based structures have been proven to act effectively as nanovalves. 
This function. One such group developed a MOF-nanovalve system where UMCM-1-NH2 acted 
as the host material and was modified with carboxylatopillar[5] arene (CP5) that is linked with 
positively-charged pyridinium stalks. When this system enters an acidic tumor cell or tissue, the 
CP5, which acts as the gatekeeper, will experience a weakening of the noncovalent bonding 
between itself and the pyridinium stalks. This weakening leads to an “opening” of the nanovalve 
and thus the MOF will now be unblocked to the environment and will release the molecules it 
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stored. This system showed negligible premature release, negligible toxicity, biodegradability and 
biocompatibility. Another system developed is based on CP5-gated Zr-MOFs to provide a tri-
stimuli-responsive effect. The three stimuli are low pH and increasing temperature which weaken 
the noncovalent bonds between CP5 and the stalks with the third stimuli being competitive binding 
since CP5 has a higher binding affinity for Ca2+ than for the stalks it is originally bound to. This 
system shows promise for future use in bone cancer therapy and bone regeneration as it showed 
controlled drug release in surroundings similar to that in osteoclasts and tumor cells which are 
generally low in pH and have high Ca2+ concentrations. These responses in conjunction with the 
high temperature response give it desirable properties and performance. Another supramolecular 
host that is of interest is 𝛽-cyclodextrin (𝛽-CD). It also works as a sort of “gatekeeper” and can be 
tethered to most MOFs. Zhang et al. developed a system where they functionalized an Fe-based 
MOF with a 𝛽-CD derivative and peptide-functionalized polymer and encapsulated the drug DOX. 
This drug carrying system possessed pH- and redox-responsiveness and when tested on tumor and 
cancer cells it showed high uptake into the tumor cells and efficient drug delivery. Wang et al. also 
developed a system where they tethered 𝛽-CD to the surface of the MOF UiO-68-azobenzene. The 
azobenzene group is able to change its isomer arrangement from cis to trans and vice-versa when 
exposed to light. The cis/trans isomerization, and more specifically the one of trans to cis, promotes 
the dethreading of the 𝛽-CD molecules and allows for delivery of the drug. It was also found that 
the compound amantadine promotes competitive binding due to the higher binding affinity that 𝛽-
CD has for amantadine causing dissociation of 𝛽-CD from the azobenzene stalks and thus, release 
of the drug. 
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 2.8.2 Pesticide Detection and Concentration 
There exists a major and continually growing concern for the health and safety of the public 
and the environment when it comes to the dangers regarding pesticides. Organophosphorous 
pesticides (OPPs) account for a large portion of concern due to its widespread use worldwide. 
OPPs are used for herbicides, insecticides, fungicides, and sprout inhibitors. These OPPs have all 
been used to increase agricultural output.  
 Currently, methods to detect the presence of OPPs are limited to characterization 
techniques based on chromatography. These methods require expensive equipment, which is not 
always widely available. In X. Xu et al, ZnPO-MOFs were synthesized to be used as a much 
cheaper alternative to detect the presence of one particular toxic pesticide. The luminescent ZnPO-
MOF studied in this paper has its fluorescence intensity quenched when in the presence of a 
pesticide. As the pesticide is absorbed into the MOF, the fluorescent activity is decreased at a 
predictable rate. The pesticide concentration was measured by observing the fluorescence intensity 
of ZnPO-MOF at various amounts of the OPP parathion-methyl. These responses were plotted 
against a titration curve of the MOF in the presence of parathion-methyl to observe the quenching 
efficiency as a function of the logarithmic concentration of the pesticide. In a real sample, this 
MOF was able to detect the concentration of the parathion-methyl with relatively high 
accuracy.  ZnPO-MOFs demonstrate a very wide range of detection of pesticides (1.0 μg kg-1 to 10 
mg kg-1) with a lower detection limit of 0.12 μg kg-1 for parathion-methyl. This high efficiency can 
be attributed to MOFs excellent adsorption ability to the analyte.36 
 2.8.3 Anti-Corrosion Coatings 
MOFs have been recently investigated for their potential anticorrosion characteristics. 
MOFs that are highly water stable and hydrophobic MOFs are good contenders for anticorrosion 
coatings. Some examples of MOFs that fit this description are ZIF-8, MIL-53, and UiO-66. 
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Previously, anti-corrosion coatings involved chromate and phosphate-based materials, 
which posed serious carcinogenic risks. 
M. Zhang et al studied ZIF-8 and its possibility to act as an anticorrosion film on aluminum plates. 
ZIF-8 demonstrated excellent anticorrosion characteristics, likely due to its intrinsic 
hydrophobicity. From this paper, it could be determined that MOFs are strong candidates for future 
use as anticorrosive films or coatings.40 
 2.8.4 Bifunctional Oxygen Electrocatalysts for Metal Air Batteries 
 
Metal-air rechargeable batteries require a bifunctional electrocatalyst for oxygen reduction 
and evolution reactions (ORR/OER). Commonly used catalysts for these batteries include Pt, Pd, 
Ni, Co, and Fe. Pt is very expensive and relatively sparse compared to Pd. The other listed 
transition metals, while demonstrating strong catalytic activity, were hindered by their relatively 
low electronic conductivity. To improve these transition metals’ conductivity, the catalyst can be 
doped with electron donors, otherwise known as metal nanoparticles. 
Due to their highly porous nature, MOFs are great structures to build these catalysts on. 
MOFs can be used as a sacrificial template to finely tune the synthesis of these catalysts. In H. Li 
et al, the pyrolysis of MOF ZIF-67 was used to synthesize Pd@PdO–Co3O4 nanocubes to be used 
as an ORR/OER catalyst. It was determined that this synthesis produced a catalyst with favorable 
electrocatalytic properties, and a high stability for both oxygen reduction and evolution reactions. 
With physicochemical characterizations, a layer of CoOOH on the surface of the PdO/Co3O4 
prevented further oxidation of the catalyst, as well as provided more active sites for OER 
reactions.41 
2.8.5 Natural Gas Storage 
Natural gas (NG), which is mainly methane gas is a favorable form of energy compared to 
other fossil fuels. This is because NG has a high hydrocarbon ratio and a lower carbon dioxide 
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emission rate compared to fossil fuels. Methane also has a lower energy density, which as limited 
its ability to be applied on a larger scale in today’s world. 
Using a sol-gel synthesis (similar to that of aerogels/xerogels), the MOF HKUST-1 was 
synthesized to experiment with its ability to store methane.  This synthesis does not require high 
pressure or binders to complete. To test the methane absorption rates, volumetric adsorption 
isotherms of methane were run at room temperature and up to 70 bar.  
It was concluded that this MOF could hold and outstanding 259 cm3 (STP) cm-3 at 65 bar. 
With such a high affinity to store methane, the practical use of NG in real world applications 
becomes a much more achievable feat.42 
  
  
 
 
    
 45 
3.0 Experimental 
3.1 HPLC Configuration Optimization 
 
In order to optimize the HPLC configuration to ensure that it has the least amount of dead 
volume possible, RTD steps with through each component were conducted. The HPLC system 
used was an Agilent 1100 with binary pumps and a 6-port VICI Valco column switching valve for 
column direction. The detector is an Agilent UV-VIS G1315-60022 diode array detector with a 
path length of 10 mm and a detection range from 190 nm – 950 nm. The injector system that was 
used was a G1313A, with a switching valve between the bypass or through the injector needle. 
The HPLC contains two solvent reservoir bottles, one with water as a carrier and one with 
Rhodamine RT at 0.1 ppt concentration in water. Injections of 5 µL of Rhodamine RT were 
introduced to the system flow to identify the concentration and wavelength needed to ensure proper 
profiles. The concentrations analyzed were: 0 ppm, 0.01 ppm, 0.1 ppm, 1 ppm, 0.001 ppt, 0.1 ppt, 
and 1 ppt. Beer’s Law analysis was then conducted on the peak intensity for each concentration to 
determine the maximum detectable concentration that would not peg out the detector. Figure 16 
shows three points plotted to get a linear fit that can be used to find the molar absorptivity. This 
value helps to determine the concentration from the HPLC. 
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Figure 16: Beer’s Law graph of Rhodamine RT at 198nm. 
 
Once the concentrations and wavelength were determined to be 1 ppt and 550 nm 
respectively, these were then used in each configuration. Figure 16 shows the setup for each 
individual run. 
 
Figure 16: Various HPLC configurations including the indicated components used in each trial 
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Overall the hope would be to include the most amount of equipment possible to maximize 
functionality while also having the least amount of dead volume that causes axial dispersion in the 
flow profiles. Each configuration was screened under six flows and these were all graphed to be 
set in bar graphs against each other. The flows were 0.5 mL/min to 3.0 mL/min with 0.5 mL 
intervals. The initial run was 15 minutes of run time with 3.5 mL/min of water and sorbate runs 
for five minutes. A runoff time of five minutes was then used for each of the flows. Results will 
be discussed in section 3.8.1. 
3.2 ZLC System Validation 
 
Ideally the system would be benchmarked against a) published sorbate/sorbent diffusion 
data in a liquid ZLC system, b) published sorbate/sorbent diffusion data in a non-ZLC system, or 
c) diffusion of an alternate sorbate/sorbent system (e.g. zeolite). However, due to the lack of 
research in the testing of liquid-based ZLC systems, this paper surmised the most effective way to 
validate our system was using the Wilke-Chang relationship to estimate the solute/solvent 
diffusion coefficient, then correct it for the confined solid pore diffusion. The Wilke-Chang 
relationship provides a method for estimating the diffusion coefficient of paracetamol in a liquid 
solvent. This theory applies to nonelectrolytes in an infinitely dilute solution and is described by 
the equation: 
 𝐷𝐴𝐵 =
7.4 ∗ 10−8(𝜙𝐵𝑀𝐵)
0.5𝑇
𝑉𝐴
0.6𝜇𝐵 
 (14) 
  
Correction factors that depend on a ratio of the solute diameter to the diameter of the pore 
are used to convert the diffusion coefficient solved by the Wilke-Chang to a diffusion coefficient 
that describes a hindered solute diffusing through solvent filled pores. This ratio is defined as: 
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 𝜑 =
𝑑𝑠
𝑑𝑝𝑜𝑟𝑒
 (15) 
The first correction factor is based on geometric arguments for stearic exclusion. The 
equation used to describe this interaction is shown below: 
 𝐹1(φ) = (1 − φ)
0.5 (16) 
The second correction factor is referred to as the hydrodynamic hindrance factor. This is 
based on the hindered Brownian motion of a solute particle moving through a solvent filled pore. 
The equation describing this motion is shown below: 
 𝐹2(𝜑) = 1 − 2.104𝜑 + 2.09𝜑
3 − 0.5𝜑5 (17) 
 
The total correction to the diffusion of a solute in a solvent is described by the equation: 
 𝐷𝐴𝑒 = 𝐷𝐴𝐵𝐹1(𝜑)𝐹2(𝜑) (18) 
3.3 Paracetamol Extraction 
 
To obtain paracetamol (acetaminophen) to be used in the pharmaceutical trials, twenty 500 
mg acetaminophen tablets (CVS brand) were crushed up by mortar and pestle. The resulting 
powder was then fully dissolved in 200 ml of ethanol. The solution was then filtered through filter 
paper. Finally, the resulting solution after filtering was heated to evaporate the remaining ethanol. 
The solid that remained in the glassware after all of the ethanol was evaporated was assumed to be 
paracetamol, while the binder remained on the filter paper as it does not dissolve in ethanol.         
8.14 g of a fluffy white solid was recovered. To characterize the solid powder, XRD analysis was 
conducted and it could be concluded that the powder was paracetamol. 
3.3.1 Paracetamol Characterization 
 
XRD data from the extracted paracetamol can be seen in Figure 17 and Figure 18. 
According to the MDI Jade software used, the material extracted was in fact paracetamol. MDI 
Jade concluded with an FOM value of 2.1 (exact match being 0).  
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Figure 17: Paracetamol XRD Results 
 
 
Figure 18: XRD results of paracetamol (white) overlayed with MDI Jade database peaks of 
paracetamol (green) 
 
 The HPLC also provided a way to compare the absorbance spectrum of the paracetamol 
through a 200 - 310 nm wavelength. The literature value that worked best for our system was found 
to be at 198 nm. DAD UV data was not included, but it showed agreement with the literature.43 
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Figure 19: Literature UV data43  
3.4 Zeolite Ion Exchange 
 
The trials for the ZLC system validation were conducted using two different zeolites. They 
are the Zeolite H-Y and the ion exchanged Zeolite-NaY. The reasoning behind picking these 
zeolites is due to their large pore openings (0.74 nm), high crystallinity, strong water stability and 
ready availability on campus. It was obtained from Zeolyst, a commercial zeolite supplier. An ion 
exchange on the zeolite was conducted to ensure that the numerical model worked across two 
different structures. In order to perform an ion exchange, 1.0 g of Zeolite Y was mixed into a        
1.0 M solution of sodium nitrate for 20 minutes. This solution was then filtered by vacuum 
filtration to remove the sodium nitrate. This washing was performed three times before drying in 
the oven for 24 hours at 100oC.44 To ensure that the product was actually ion exchanged, XRD 
was conducted on the sample.  
Figure 20 showed the graph compared the Zeolite-NaY that was constructed to the baseline 
in MDI Jade package. The yield in physical material from the washing was 12% based on a mass 
balance. Lower yields likely arose from the poor seal on the vacuum pump and the use of large 
pore filter paper that allowed for most of the sample to permeate. While this was not the ideal 
situation, the axial dispersion in the ZLC meant that small amounts were needed for the trials in 
the HPLC. 
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Figure 20: XRD graph of Zeolite NaY (white line) and green markers denoting the location of 
peaks for a Zeolite NaY from MDI Jade. 
The baseline of the XRD shows the structure of a faujasite (FAU) according to the MDI 
Jade program. The program found that the Zeolite-NaY that was tested was similar with an FOM 
of 1.8 (exact match being zero) to the Zeolite-NaY in its database. The similarity means that the 
ion exchange was successful and that it was stable even after drying. 
 
3.5 Zeolite Diffusion Trials 
 
After the system was configured to the most realistic dead volume without waste, Beer’s 
Law analysis was conducted on the paracetamol that was previously synthesized. Concentrations 
of 0.001 g, 0.005 g, 0.01 g, and 0.021 g were used and then 0.0673 g was chosen at a wavelength 
of 198 nm. The concentration of 0.001 g/1.5 mL was still too high when converting to 1 L, so a 
magnitude dilution of 10 was don’t to bring it to a concentration of 1 ppt that is used throughout 
all the trials. Trials on the paracetamol were conducted were using the configuration from the first 
2-Theta (degrees) 
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te
n
si
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mixing spot to the detector, or Configuration 1. The first trial involved taking the uptake and 
release profile of the paracetamol without the ZLC being packed as a background. This run help 
to normalize the data set through the zero-length column with the zeolite and later the MOF trials. 
Once the background is taken, 5 mg of the zeolite (Zeolite Y for the first two trials and then    
Zeolite-NaY for the other three trials) was added and washed with 300 mL of water to remove fine 
particles that could clog the downstream tubing. The trials for the zeolites were conducted with 
flows of 0.5 mL/min to 3.0 mL/min with intervals of 0.5 mL/min. Initially three different 
timescales for the sorbate was used to find determine if the peak absorbance was occurring and 
that there was a profile that could be found for the steps. There was no difference to be seen in the 
peaks so a consistent run time of 5 min was used for all trials in the report besides these three. A 
runoff of 60 minutes for each flowrate. The desorption profiles from these steps are then used to 
find the residence time of the paracetamol in the zeolite to be entered into the mathematical model 
that was created. 
 
3.6 MOF Synthesis 
 
To synthesize IRMOF-1 for use in the HPLC, the synthesis described in Sabouni, R et al.2 
was used. 0.947 g of zinc nitrate hexahydrate and 0.176 g of terephthalic acid (TPA) powders were 
separately weighed out. Each powder was then transferred into a 25 ml Teflon reactor. 10 ml of 
diethylformamide (DEF) was added to the teflon reaction vessel. The resulting mixture was mixed 
well to dissolve the powders into the solvent. Once fully dissolved, the teflon reactor was capped, 
and inserted into a pressure bomb. The bomb was fully tightened and the capsule was placed in a 
100oC oven for 20 hours. After the 20 hour crystallization period, the pressure bomb was removed 
from the oven and the reaction was quenched by placing the capsule in room temperature water. 
After quenching the reaction, the contents of the teflon reactor were transferred into a vial to be 
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used in a centrifuge. The batch was centrifuged at 1500 RPM for 20 minutes. The remaining 
solvent was decanted from the top. Approximately 15 ml carbon tetrachloride was added to the 
dried crystals, and the centrifuge process was repeated. Finally, after the crystals were decanted a 
second time, the contents were placed into a petri dish and left in the oven at 100oC overnight and 
weighed the following day. 
3.6.1 MOF Characterization 
 
To characterize the frameworks synthesized, x-ray diffraction and physisorption methods 
were used. The XRD data can be found below. This curve was compared to literature data. The 
peaks at 9 and 17 are very prominent, which strongly suggests the presence of IRMOF-1 in the 
sample. For a more detailed analysis of this characterization and possible degradation, refer to 
section 4.5. 
 
 
Figure 21: First IRMOF-1 Synthesis 
 54 
 
Figure 22: Second IRMOF-1 Synthesis 
 
The physisoprtion data was acquired from the program Quantachrome® ASiQwin™ 
through the Autosorb iQ Station. The trial was run with a Nitrogen Adsorbate model using a 
temperature of 77.35K and a pressure of 33.5 atm. The trial ended prematurely after four points 
due to the low amount of sample (0.0281 g degassed) that was used. Such a small amount of MOF 
was used because the synthesis did not provide enough for the 0.05 g that is typically used. The 
resulting micropore surface area was found through the Dubinin-Radushkevich (DR) equation that 
is selective for larger pore sizes and uses the region points that were available. The resulting 
micropore surface area was 82.601 m2/g and a micropore volume of 0.0299 cm3/g. The literature 
values for IRMOF-1 was 450 m2/g and 0.18 cm3/g.45 The reason for the difference is discussed in 
section 4.5.  
 
3.7 MOF Trials 
The amount of MOF loaded into the ZLC was 5mg and this was washed through with 300 
mL of water to clear out the fine particles. Trials with the MOF were conducted were using the 
same method and configuration from the trials with the zeolites in Section 3.5. Figure 23 shows 
the data from the HPLC as steps. The peaks are when running the sorbate, paracetamol, and the 
valleys are the washout with water.  
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Figure 23: Example of steps from HPLC. This trial is paracetamol at 198nm through IRMOF-1. 
3.8 Mathematical Model 
3.8.1 System Optimization 
 
The main procedure towards optimizing the system involved testing different HPLC 
configurations and measuring residence time of Rhodamine-WT. Initially, raw data from the 
HPLC was collected (Figure 24)  and normalized using Equation (17).   
  
Figure 24: HPLC raw data with red box indicating desorption profile 
 
 𝐷𝑖𝑚𝑒𝑛𝑠𝑖𝑜𝑛𝑙𝑒𝑠𝑠 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 =
𝑦 − 𝑦𝑚𝑖𝑛
𝑦𝑚𝑎𝑥 − 𝑦𝑚𝑖𝑛
=
𝐶
𝐶𝑜
 (19) 
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Y is the absorbance at any point in time, Ymin is the minimum absorbance value (baseline 
value), and Ymax is the maximum absorbance value corresponding to the initial concentration in 
the liquid. All “Y” values in Equation (19) are taken from the desorption region of the HPLC data, 
which is outlined with a dashed red line in Figure 24. After the concentration was normalized it 
was fit to an exponential decay using Equation (20). This exponential fit data was then plotted vs 
time, shown in Figure 25 below. 
 
Figure 25: Normalized Concentration on Log-Scale vs. Time 
The region circled in red is the short time region, or the washout region. The slope of this 
region is equal the negative value of the residence time, so multiplying the slope by negative one 
gives the residence time. This slope was found by using the polyfit function in Matlab for a first 
order polynomial. Once the residence time is found, it is converted from minutes to seconds and 
plotted against the inverse of the flow rate it. According to Equation (20) the plot of the inverse 
flow rate vs residence time should have a slope equal to the dead volume of the system. 
 𝑉𝐷 = τ ∗ F (20) 
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In Equation (20), VD is the dead volume, ⲧis the residence time, and F is the flow rate of 
the liquid phase. An example of this plot can be seen in Figure 26, which shows the same 
configuration tested 3 times to show that results are repeatable. 
 
 
Figure 26: Residence Time (tau) vs. Inverse Flowrate showing a linear relationship in accordance 
with equation (20) 
 
This full procedure to find dead volume was done in Matlab for different configurations at 
various flow rates. Once each configuration is tested and dead volume calculated, they were plotted 
on a bar graph so that the differences for each configuration could be seen clearly.  
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Figure 27: Comparison of Dead Volume for Different Configurations 
The 0.5 mL of dead volume is significantly larger than the overall volume of the sorbent. 
There is only 0.001 mL of MOF/zeolite as 5 mg were added at a density of 0.5 g/cm3. 
Configuration 4 was chosen to best minimize the overall dead volume to ensure that long 
desorption profiles were not needed to beat the washout time. Configuration 4 was not as efficient 
with the sorbent in the ZLC, possibly due to increased turbidity in the column due to the particles 
presence. When the zeolite was washed out of the ZLC, it was found to affect the dead volume in 
the system. Further trials with Zeolite Y and Zeolite-NaY saw the dead volume rise initially and 
then decrease with Configuration 4 to 1.5 mL for Zeolite-Y and 0.45 mL for Zeolite-NaY. This is 
likely due to dispersion in the ZLC chamber as a result of particles blocking the flow path. These 
are the values that are used in the results when running the Matlab script to fit the ZLC model to 
the data. 
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3.8.2 Diffusivity Modeling 
Diffusivity modeling was carried out in Matlab by numerically solving the solid phase 
mass balance (Equation (8)). A Matlab script was created to solve Equation (8) as a boundary 
value problem using Equations (9) and (10) as initial conditions and the first boundary condition 
at the center of the particle, respectively. The final boundary condition for concentration at surface 
of the particle must be solved for simultaneously with the overall mass balance by an estimated 
diffusion coefficient. The overall goal is to create a model that reproduces the profiles in Figure 
25 as accurately as possible, with emphasis on accurately modeling the slope of the long-time 
region which is circled in black. The final script numerically solves Equation (8) and will 
accurately approximate data from the ZLC at different flow rates when provided with a proper 
estimation for DAB.  
The concentrations were normalized and plotted versus time. The main procedure to solve 
Equation (8) as a boundary value problem in Matlab was to use the bvp4c function. This function 
evaluates the solid phase mass balance using appropriate boundary conditions and initial 
conditions. The variables q and r were represented in Matlab by y and x.  
The boundary condition at the center of the particle was set so that the change in 
concentration at the center of the particle was zero due to symmetry. At the surface, the boundary 
condition defines the concentration as a function of the particle radius, particle volume, diffusivity, 
system dead volume, mobile phase flow rate, and Henrys constant between the mobile phase and 
particle surface. This boundary condition is defined below: 
  𝐶𝑠 =
−𝑉𝑓 ∗ 𝐿
𝐹 ∗ 𝑅2
∗
𝑑𝑞
𝑑𝑡
−
𝐿
𝑅2
∗ 𝑦1 (21) 
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In Equation (21), Vf is dead volume, F is mobile phase flow rate, R is particle radius, y is 
the concentration of the sorbate, and L is a variable related to flow rate, particle radius, particle 
volume, Henrys constant, and diffusivity. The variable L is defined below in Equation (22). 
 𝐿 =
1
3
∗
𝐹 ∗ 𝑅2
𝐾 ∗ 𝑉𝑠 ∗ 𝐷𝐴𝐵
 (22) 
Where Vs is the volume of the particle and K is the Henry Constant. Since the concentration 
being calculated is normalized, the initial concentration was set to q=1 at t=0.   
Since the bvp4c function can only solve for one solution at a time, Equation (8) is only 
evaluated after a single “time step”.  
In order to get a solution over the full period of time, a for loop was created to evaluate the 
equation between t=0 and the final time, tf. All values for concentration, or y, are defined in a 
vector of a length the time vector plus one. The value of y1 and y0 are defined as the value of y at 
column “i” and “i-1” in the theta vector, respectively. This allows for the mass balance to be 
evaluated with the proper concentrations over the full length of time.  
Having properly input the equation into Matlab, the resulting concentration were plotted versus 
time. The diffusivity DAB is changed (tuned) until the desorption profiles match those obtained 
from the ZLC. Therefore, the value of DAB that gave the proper profile is the diffusion coefficient 
of our material. A copy of the code can be found in Appendix B: Matlab Code. 
In addition to the Matlab model, a simplified analytical solution to the math model was 
also used for rapid verification of our system. This version assumes that there is no fluid-phase 
hold-up which reduces the equations22: 
 
𝑐(𝑡)
𝑐𝑜
= ∑
2𝐿
𝛽𝑛2 + (1 − 𝐿 + 𝛾𝛽𝑛2)2 + 𝐿 − 1 + 𝛾𝛽𝑛2
 𝑥 exp (−𝛽𝑛
2
𝐷
𝑅2
𝑡) 
 
(23) 
 𝛽𝑛𝑐𝑜𝑡𝛽𝑛 + 𝐿 − 1 − 𝛾𝛽𝑛
2 = 0 (24) 
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Where Equation (23) is the desorption curve model and Equation (24) is down to the form of: 
 
𝑐
𝑐𝑜
= 2𝐿 ∑
exp [−𝛽𝑛
2 (
𝐷
𝑅2
) 𝑡]
𝛽𝑛2 + 𝐿(𝐿 − 1)
 
 
(25) 
 
𝛽𝑛𝑐𝑜𝑡𝛽𝑛 + 𝐿 − 1 = 0 
 
(26) 
This assumption allows for ease of calculation of diffusion coefficient. However, values 
calculated from this model are only meant to be used as a reference for the full model since this is 
an oversimplification of the system.22 
3.9 Safety 
Proper safety precautions in regards to typical lab protective equipment was utilized. Nitrile 
gloves were sufficient for the chemicals used while thermal gloves were used for removing 
samples from the oven. The zeolite was ion exchanged and loaded into the ZLC in the presence of 
a fume hood due to its ability to irritate lungs and eyes. The ion exchange utilized a sodium nitrate 
base that was properly diluted to safe pH to be disposed of in the sink. When setting up the pressure 
chamber for the MOF drying, it was filled to less than half way to ensure that the solvent 
evaporation did not cause an explosion due to pressurization. Links to the SDS pages for sodium 
nitrate, teraphalic acid, Zeolite Y, zinc nitrate hexahydrate, and diethylformamide can be found in 
Appendix C: SDS Sheets. 
  
 62 
4.0 Results and Discussion 
 
4.1 Particle Size and Volume Distribution 
 Images of our suspension of particles were taken with one sample shown in Figure 29 using 
an optical microscope. These images were analyzed using the Particle Analysis Method in the 
ImageJ software to obtain particle size and volume distributions as shown in Figure 30 and Figure 
31. The montage shown in Figure 28 below shows the process by which these particles were 
analyzed. 
 
 
Figure 28: Montage of Steps for Particle Analysis Method 
 
Figure 29: Optical Image of MOF-5 Particles 
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The mean particle size was shown to be ~6 μm and approximately 1600 particles having a 
volume equal to or less than 500 μm3. However, there were 500 particles recorded to have volumes 
equal to or greater than 10,000 μm3. This may be due to agglomerates not being completely 
watershed during the analysis process, thus they were deemed artifacts and were omitted from 
further analysis.  
 
Figure 30: Particle Diameter Distribution Using Data from ImageJ  
 
 
Figure 31: Particle Volume Distribution Using Data from ImageJ 
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4.2 Analysis of Methods Used for Modelling 
 The raw data from desorption curves of the HPLC with no species in the ZLC were run 
through two different programs to understand the differences and the selectivity of a numerical 
solution versus an approximate analytical solution. The approximate analytical solution was run 
through an excel file that fit the parameters of a gas phase mobile phase was the case in Brandini 
and Ruthven. The numerical solution was solved using a boundary value problem and partial 
differential equation script in Matlab to model the short and longtime profile of the desorption 
curve. With the Matlab script, the raw data was converted to dimensionless concentration and 
plotted on a log scale vs time. In order to understand the background to the data that was being 
collected, the first trial that was run through the two analyses was the baseline. The baseline graph 
of paracetamol through a ZLC with just the two frits inside can be seen in Figure 32 (A). The 
baseline as shown in the figure shows that the model approximates an empty cell when the 
diffusion coefficient would be approaching infinity.  
 
 
 
Figure 32: (A) Normalized desorption profile through an empty ZLC chamber. F = 0.5 ml/min  
(B) Baseline of ZLC run in Excel (blue) and fit (red), F = 0.5 ml/min 
 
A B 
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Figure 32 shows the washout dominated over a diffusion coefficient. No diffusion model 
was able to accurately describe the desorption profile. The closest fit (shown in Figure 32 (B)) 
resulted in a diffusion coefficient of 3.78 x 10−14
𝑚2
𝑠
   using the excel gas phase method. The 
Matlab version was unable to fit the long-time region as the washout occurred too rapidly.  
4.3 Diffusion Measurements in Zeolite System Validation  
 
 4.3.1 Approximate Analytical Model Fitting 
Zeolite-Y and Zeolite-NaY were both tested to show that the system works before 
IRMOF-5 was used. As shown in Figure 33, Zeolite-Y is substantially different from the control 
data (blank cell). This data shows close agreement with the fit line as the time range chosen for 
fit was 400-800 seconds since this is where the long-time occurs for these data sets. Both fits 
produced diffusion coefficients within 3% of each other and the values produced show that 
Zeolite-Y is not affected by the presence of water as the average diffusion coefficient calculated 
was 2.82 x 10-16 m2/s. This is two orders of magnitude smaller than that of the measured baseline 
which means that there is holdup in the zeolite structure that is removed after washout. 
  
Figure 33: (A) Zeolite-Y Trial 1, F = 0.5 ml/min, (B) Zeolite-Y Trial 2, F = 0.5 ml/min 
Zeolite-NaY was tested within the column using three different uptake times (one minute, 
five minute, and one hour) to ensure that the proper peak was reached before desorption began. 
The three did not have an appreciable difference and the standard 5 min runs that were used in all 
A B 
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trials was chosen. Figure 35 shows dimensionless concentration profiles of the different uptake 
times fit to the same model. The model fit well to the experimental data and produced similar 
diffusion coefficients as shown in Table 2. The change in the start of the long-time diffusion may 
be because there was not as much paracetamol allowed to saturate the Zeolite-NaY so the washout 
time was quick. 
 
Figure 34: Normalized Raw Data for One Hour Uptake (red), Five Minute Uptake (light green), 
and One Minute Uptake (blue) 
 
Figure 35: Comparison of Zeolite-NaY Uptake Times; Five Minute (light green), Five Minute Fit 
Line (purple), One Hour (red), One Hour Fit Line (light blue), One Minute (dark blue), and One 
Minute Fit Line (yellow) 
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Table 2: Uptake time comparison based on Diffusion Coefficient of Zeolite-Y 
Trial Diffusion Coefficient (m2/s) 
Zeolite-NaY One Minute 5.76 x 10-16 
Zeolite-NaY Five Minute 1.09 x 10-15 
Zeolite-NaY One Hour 8.31 x 10-16 
 
Each trial was run with a five-minute uptake and thus, comparatively, Zeolite-Y showed a 
lower diffusion coefficient than that of Zeolite-NaY as shown in Table 3. This may be occurring 
because in the ion exchange, hydrogen ions are being replaced by sodium ions. In addition to this, 
the zeolite is also becoming partially dealuminated meaning that the structure is now becoming 
more porous and thus will allow the paracetamol to diffuse more rapidly into and out of the ion-
exchanged zeolite. Lee and Rees performed the same ion-exchange, instead using HCl as the acid, 
and 56% of the framework aluminum was released.46 
 
Table 3: Diffusion coefficient comparison between Zeolite-Y and Zeolite-NaY 
Trial Diffusion Coefficient (m2/s) 
Zeolite-Y 5 Minute Trial 1 2.79 x 10-16 
Zeolite-Y 5 Minute Trial 2 2.85 x 10-16 
Zeolite-NaY 5 Minute Trial 1 1.09 x 10-15 
 
 4.3.2 Numerical Solution Fits of Zeolite Runs 
The numerical analysis with Matlab showed the same trends as the gas phase model found 
but it ultimately found diffusion coefficients that were significantly lower than previously thought. 
Figure 36 show the profiles for the trials.  
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Figure 36: (A) Zeolite Y trial 1, F = 0.5 ml/min, strong agreement is observed at both short and 
long times, (B) Zeolite NaY trial 1, F = 0.5 ml/min, (C)  Zeolite NaY One Minute Uptake, F = 
0.5 ml/min, (D) Zeolite NaY One Hour Uptake, F = 0.5 ml/min, note time scales 
 Table 4 and Table 5 have the values for each trial in a way that makes them easy to 
compare. They all are slower than the baseline diffusion which means that washout did not 
dominate the whole ZLC. An interesting result was that the five minute uptake of paracetamol in 
Zeolite-NaY produced the slowest diffusion coefficient out of all the trials. It is possible that it 
was an outlier or there could be more going on there. The scale of the diffusion is consistent with 
literature values of a liquid phase with solid molecules going through zeolites. Literature shows 
that diffusion of molecules through a porous media of approximately 2 nm is around 10-12 m2/s.47,48  
A 
D C 
B 
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Table 4: Uptake time comparison based on Diffusion Coefficient of Zeolite-Y 
Trial Diffusion Coefficient (m2/s) 
Zeolite-NaY One Minute 2.24 x 10-12 
Zeolite-NaY Five Minute 1.4 x 10-13 
Zeolite-NaY One Hour 2 x 10-12 
 
Table 5: Diffusion coefficient comparison between Zeolite-Y and Zeolite-NaY 
Trial Diffusion Coefficient (m2/s) 
Zeolite-Y 5 Minute Trial 1 5.6 x 10-13 
Zeolite-NaY 5 Minute Trial 1 1.4 x 10-13 
 
 
4.4 IRMOF Results 
 4.4.1 IRMOF Diffusion Coefficient Model 
Raw data of the adsorption of paracetamol onto the surface of IRMOF-1 was converted to 
dimensionless concentration. The simplified model was used to predict the diffusion coefficient of 
IRMOF-1. Figure 37 show fits to the IRMOF-1 data and these fits do not agree well with the long-
time data as well within the 50-200 second time range fitted. This is a result of the degradation of 
the diffusivity properties of IRMOF-1. This occurs because when water interacts with IRMOF-1, 
water blocks active sites on the surface of the MOF and does not desorb and thus the MOF is not 
able to work properly.51 Humidity in the process of construction of the MOF can lead to improper 
synthesis and lead to washout of MOF components in the liquid system. Figure 37 (D) shows the 
MOF data run through the Matlab script. The diffusion coefficient being ten to the negative eight 
means that washout is dominant in the ZLC and that the IRMOF is not having any uptake of the 
paracetamol and is rather just a product of a change in dead volume. 
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Figure 37: (A) Data Fit with IRMOF-1; dimensionless concentration (blue) and fit curve (red), F 
= 0.5 ml/min, (B) Data Fit with IRMOF-1; dimensionless concentration (blue) and fit curve 
(red), F = 0.5 ml/min, (C) Data Fit with IRMOF-1; dimensionless concentration (blue) and fit 
curve (red), F = 0.5 ml/min, (D) Matlab Model for MOF Diffusivity showing the short-time 
desorption profile model. Long time diffusion is indistinguishable from background detector 
noise, F = 0.5 ml/min 
This phenomenon is more obvious when using our model to estimate the diffusion 
coefficients for three sets of MOF data and a blank data set. As shown in  
Table 6, the diffusion coefficients show great agreement with each other which is expected 
because if the active sites on IRMOF-1 are not available for paracetamol to adsorb onto then the 
solution will just flow around it and so it will show a diffusion coefficient to that of the blank run. 
See section 4.5 for more detail. Another observation that makes sense is that the diffusion 
coefficients of the MOF trials is slightly less than that of the blank run. This is because even though 
the paracetamol is not able to adsorb to the MOF, the presence of the MOF presents a hindrance 
A B 
C D 
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to flow and thus diffusion coefficient should be slightly lower than that of the blank run. Washout 
dominates the system and there is only a slight deviation in dead volume which leads to the change 
in what is found to be a diffusion coefficient.  
Table 6: IRMOF-1 and Blank Diffusion Coefficient Values 
Trial Diffusion Coefficient (m2/s)* 
Blank 3.78 x 10-14 
IRMOF-1 Trial 1 2.49 x 10-14 
IRMOF-1 Trial 2 1.91 x 10-14 
IRMOF-1 Trial 3 2.65 x 10-14 
*These values were model fits that do not physically represent the intraparticle diffusion 
coefficient 
Lastly, all of the compounds were overlaid and compared in Figure 38. It is shown that the 
IRMOF-1 data and the Blank run show similar profiles and overlap which is expected since the 
IRMOF-1 active sites for adsorption are being blocked by water molecules. Zeolite-Y and Zeolite–
NaY, however, show much slower desorption profiles representing that paracetamol is able adsorb 
to the surface and desorb accordingly. These zeolites show the ability for controlled drug release 
by modifying Zeolite-Y used for drug storage. Slower release profiles can thus be achieved by 
continuing to modify the Zeolite-Y or Zeolite-NaY structures.  
 
Figure 38: Comparison of Blank (light blue), IRMOF-1 Trial 1 (yellow), IRMOF-1 Trial 2 
(gray), IRMOF-1 Trial 3 (orange), Zeolite-NaY (blue), and Zeolite-Y (light green) 
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4.4.2 IRMOF-1 Results Compared to Model 
The IRMOF-1 data was compared to more than one model used for estimating the diffusion 
coefficient. One such model used was the Wilke-Chang relationship. This model looks at hindered 
solute diffusion through tiny capillary holes. As shown in Table 7, the Wilke-Chang relationship 
predicts a diffusion coefficient that is three orders of magnitude faster than that of the average 
measured IRMOF-1. One reason for this may be that the Wilke-Chang relationship assumes an 
infinitely dilute solution which can mean that the solute molecules are only interacting with the 
solvent molecules and not other solute molecules. This means that the model is not accounting for 
additional interactions that the acetaminophen is experiencing. This assumption does not hold up 
since the concentration of the acetaminophen used for running trials was one part per thousand 
which is far beyond the assumption of infinitely dilute. Another reason this model may not be 
accurately predicting the diffusion coefficient is that the molal volume had to be estimated using 
Table 24.5 from Fundamentals of Momentum, Heat, and Mass Transfer (Welty).5 The molal 
volume is proportional to the diffusion coefficient by the –0.6 power so it can play an important 
role in the final diffusion coefficient value. It may also be possible that the correction factors may 
under predict the diffusion coefficient as it does not account for how tortuous the path of diffusion 
is. 
Table 7: Comparing Wilke-Chang Relationship to Experimental Data 
 Diffusion Coefficient (m2/s) 
Wilke-Chang 1.42 x 10-11 
Avg. IRMOF-1 2.35 x 10-14 
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4.5 Impurities in MOF 
 
Upon analysis of the XRD characterization of the MOF, it could be determined that the 
crystals were in the presence of the unreacted terephthalic acid and zinc nitrate hexahydrate from 
the synthesis. As can be seen in the figures below, there are peaks that match between the MOF 
XRD pattern and the XRD patterns of the precursors.  
There are a few possible explanations for this contamination. (1) The duration of the 
crystallization period followed from Sabouni, R et al (2010)2 was not long enough, which left 
some of the precursors unreacted, (2) the cleaning process post-synthesis was not sufficient, or (3) 
the crystal structure of the MOF was compromised due to humidity in the environment.  
As can be seen in Figure 39, a peak at 23 seems to correlate between the synthesized 
IRMOF-1 samples, as well as zinc nitrate hexahydrate from Figure 40.  
 
 
 
Figure 39: XRD results from first (top) and second (bottom) MOF syntheses 
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Figure 40: XRD Pattern of Zinc Nitrate Hexahydrate49 
 
Figure 41: XRD Pattern of Terephthalic Acid50 
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To prevent leftover precursor from remaining in the powdered MOF, this research suggests 
that the cleaning process post-synthesis should be improved. The centrifugation step of the 
cleaning process should be repeated at least 5 times to ensure that any unreacted precursor. 
According to Ming et al, MOF-5’s properties are limited due to absorption of water due to 
humidity in the air. This could cause the crystal structure to swell and deform, which could cause 
unexpected peaks, or shift the peaks’ locations in the XRD data.51 Figure 42 overlays the XRD 
data obtained from the IRMOF-1 synthesis to the data collected by Ming et al. The peaks at 2-
theta values of 9 and 17 strongly correlate with each other. This suggests that the IRMOF-1 crystal 
structure degraded in the presence of water before XRD data could be collected.51 
 
Figure 42: XRD of MOF-5 at multiple time steps in the presence of a 61% humidity 
environment51  
To alleviate this issue of degradation, Asiabi et al. has modified MOF-5 with a methyl 
group, which has proven to prevent the degradation of the framework when in the presence of 
water to a degree.52 
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5.0 Conclusion 
5.1 Main Findings 
 
The main findings of this MQP regard the successful modeling of desorption profiles in a 
ZLC model using Zeolites-Y and Zeolite-NaY, the synthesis and characterization of IRMOF-1, 
and the degradation of the structure of IRMOF-1 in water. Due to the data from the HPLC from 
the trial with a blank column and with IRMOF-1 being nearly identical, it can be concluded that 
IRMOF-1 degrades in water making it a poor candidate for drug delivery. The mass balance around 
the ZLC proposed by Brandani & Ruthven was solved numerically, yielding desorption profiles 
that accurately predict HPLC data in both the short time (washout) and longtime regions.  
5.2 Future Work 
For future work, it is recommended to use a more water stable MOF, such as HKUNST-1, 
or MOFs with different pore sizes for diffusive property studies. Furthermore, it is recommended 
that different APIs (i.e. cancer treatment drugs) are studied that have different particle sizes as the 
desorption profiles will change with different sorbents and MOF structures. Additionally, using a 
solvent and temperature that mimics the environment in the human body would be more accurate 
for drug delivery studies.  
Direct work that could be done to further the work made in this project would be to vary 
the amount of MOF or Zeolite into the system. This project assumed axial dispersion in the ZLC 
because diffusion is typically obtainable through common projections of diffusion through a few 
molecules. While this is typically true, it is something that would bolster the argument and ensure 
that nothing happens with a variance in amounts. Finally, determining the effects that higher flow 
rates have on the diffusion of the API in the MOF or zeolite would also be important, as our study 
showed the effects but the ultimate scope of the project didn’t include indexing the flow rates, but 
rather focused on obtaining a model for both the zeolite and the MOF individually.   
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Appendix A: Raw Data 
Na 1 hour steps  Na 1 min steps 
Absorbance Time  Absorbance Time 
1836.8 310.03  1829.36 194.05 
204.05 310.7  119.29 194.71 
68.15 311.36  30.01 195.38 
33.93 312.03  9.89 196.05 
21.68 312.7  4.08 196.71 
15.28 313.36  1.56 197.38 
10.64 314.03  0.32 198.05 
7.29 314.7  -0.37 198.71 
4.84 315.36  -0.78 199.38 
3.26 316.03  -1.3 200.05 
1.46 316.7  -1.67 200.71 
0.48 317.36  -1.82 201.38 
-0.37 318.03  -2.1 202.05 
-0.74 318.7  -2.41 202.71 
-1.33 319.36  -2.59 203.38 
-1.7 320.03  -2.76 204.05 
-1.66 320.7  -3.01 204.71 
-2 321.36  -2.98 205.38 
-1.92 322.03  -2.93 206.05 
-2.11 322.7  -3.15 206.71 
-2.19 323.36  -3.1 207.38 
-2.29 324.03  -3.24 208.05 
-2.48 324.7  -3.03 208.71 
-2.4 325.36  -3.36 209.38 
-2.37 326.03  -3.35 210.05 
-2.44 326.7  -3.36 210.71 
-2.51 327.36  -3.09 211.38 
-2.61 328.03  -3.29 212.05 
-2.6 328.7  -3.31 212.71 
-2.67 329.36  -3.14 213.38 
-2.51 330.03  -3.3 214.05 
-2.56 330.7  -3.4 214.71 
-2.73 331.36  -3.44 215.38 
-2.73 332.03  -3.3 216.05 
-2.81 332.7  -3.35 216.71 
-2.58 333.36  -3.21 217.38 
-2.71 334.03  -3.35 218.05 
-2.77 334.7  -3.1 218.71 
-2.74 335.36  -3.21 219.38 
-2.88 336.03  -3.42 220.05 
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-2.9 336.7  -2.86 220.71 
Na 1 hour steps  Na 1 min steps 
Absorbance Time  Absorbance Time 
-3.06 337.36  -3.06 221.38 
-2.86 338.03  -2.91 222.05 
-2.71 338.7  -2.94 222.71 
-2.9 339.36  -2.81 223.38 
-2.83 340.03  -2.84 224.05 
-2.89 340.7  -2.84 224.71 
-2.9 341.36  -2.79 225.38 
-2.87 342.03  -3.09 226.05 
-3.09 342.7  -2.92 226.71 
-2.92 343.36  -2.94 227.38 
-3.23 344.03  -2.95 228.05 
-3.18 344.7  -2.88 228.71 
-3 345.36  -2.91 229.38 
-3.15 346.03  -2.78 230.05 
-3 346.7  -2.82 230.71 
-2.87 347.36  -2.98 231.38 
-3.15 348.03  -2.92 232.05 
-3.27 348.7  -2.86 232.71 
-3.21 349.36  -2.95 233.38 
-3.04 350.03  -2.87 234.05 
-3.19 350.7  -2.9 234.71 
-3.08 351.36  -2.88 235.38 
-3.25 352.03  -2.98 236.05 
-3.33 352.7  -2.87 236.71 
-3.3 353.36  -2.85 237.38 
-3.24 354.03  -2.66 238.05 
-3.06 354.7  -2.94 238.71 
-3.19 355.36  -2.71 239.38 
-3.11 356.03  -2.8 240.05 
-3.11 356.7  -2.88 240.71 
-2.81 357.36  -2.77 241.38 
-3.1 358.03  -2.77 242.05 
-3.01 358.7  -2.87 242.71 
-3.23 359.36  -3.02 243.38 
-3.18 360.03  -2.86 244.05 
-3.24 360.7  -2.78 244.71 
-3.14 361.36  -2.87 245.38 
-3.19 362.03  -2.9 246.05 
-3.24 362.7  -2.86 246.71 
-3.16 363.36  -2.75 247.38 
-3.41 364.03  -2.92 248.05 
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Na 1 hour steps  Na 1 min steps 
Absorbance Time  Absorbance Time 
-3.14 364.7  -2.85 248.71 
-3.22 365.36  -2.85 249.38 
-3.12 366.03  -2.86 250.05 
-3.42 366.7  -2.94 250.71 
-3.19 367.36  -2.8 251.38 
-3.04 368.03  -2.89 252.05 
-3.4 368.7  -2.79 252.71 
 
Na March 
11   Without MOF 
Absorbance Time  Absorbance Time 
1830.4 210.05  2121.85 274.95 
124.28 210.72  -5.92 275.62 
49.68 211.39  -6.61 276.28 
31.18 212.05  -7.15 276.95 
22.43 212.72  -7.4 277.62 
15.58 213.39  -7.64 278.28 
11.24 214.05  -7.42 278.95 
8.79 214.72  -7.67 279.62 
6.91 215.39  -7.57 280.28 
5.94 216.05  -7.64 280.95 
5.41 216.72  -7.96 281.62 
4.71 217.39  -7.68 282.28 
4.48 218.05  -7.64 282.95 
4.31 218.72  -7.82 283.62 
3.78 219.39  -7.82 284.28 
3.85 220.05  -7.67 284.95 
3.75 220.72  -7.66 285.62 
3.64 221.39  -7.5 286.28 
3.8 222.05  -7.69 286.95 
3.43 222.72  -7.6 287.62 
3.64 223.39  -7.66 288.28 
3.19 224.05  -7.81 288.95 
3.47 224.72  -7.69 289.62 
3.47 225.39  -7.75 290.28 
3.39 226.05  -7.7 290.95 
3.52 226.72  -7.77 291.62 
3.48 227.39  -7.73 292.28 
3.41 228.05  -7.62 292.95 
3.05 228.72  -7.78 293.62 
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Na March 11 Without MOF 
Absorbance Time  Absorbance Time 
3.38 229.39  -7.76 294.28 
3.41 230.05  -7.68 294.95 
3.6 230.72  -7.86 295.62 
3.76 231.39  -7.53 296.28 
3.65 232.05  -7.92 296.95 
3.47 232.72  -7.61 297.62 
3.76 233.39  -7.5 298.28 
3.58 234.05  -8.04 298.95 
3.55 234.72  -7.64 299.62 
3.57 235.39  -8.03 300.28 
3.55 236.05  -7.87 300.95 
3.64 236.72  -7.78 301.62 
3.65 237.39  -7.86 302.28 
3.73 238.05  -8.15 302.95 
3.77 238.72  -7.97 303.62 
3.64 239.39  -7.99 304.28 
3.81 240.05  -7.72 304.95 
3.75 240.72  -8.08 305.62 
3.65 241.39  -7.87 306.28 
3.78 242.05  -8.11 306.95 
3.79 242.72  -8.07 307.62 
3.83 243.39  -7.86 308.28 
3.74 244.05  -7.97 308.95 
3.47 244.72  -7.9 309.62 
3.67 245.39  -7.73 310.28 
3.71 246.05  -8.13 310.95 
3.83 246.72  -8.05 311.62 
3.76 247.39  -7.94 312.28 
3.61 248.05  -8.14 312.95 
4.06 248.72  -7.9 313.62 
3.93 249.39  -7.87 314.28 
3.73 250.05  -7.82 314.95 
3.93 250.72  -7.99 315.62 
3.76 251.39  -8.03 316.28 
3.79 252.05  -8.26 316.95 
3.89 252.72  -8.21 317.62 
3.51 253.39  -7.7 318.28 
3.31 254.05  -7.97 318.95 
3.79 254.72  -8.09 319.62 
3.92 255.39  -7.92 320.28 
3.82 256.05  -8.24 320.95 
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Na March 11 
 
 
 
 
Without MOF 
Absorbance Time  Absorbance Time 
3.85 256.72  -8.09 321.62 
3.94 257.39  -8.07 322.28 
3.9 258.05  -7.97 322.95 
3.9 258.72  -8.13 323.62 
3.91 259.39  -8.03 324.28 
4.02 260.05  -8.14 324.95 
3.87 260.72  -8.24 325.62 
3.85 261.39  -8.25 326.28 
3.93 262.05  -8.16 326.95 
3.65 262.72  -8.12 327.62 
3.93 263.39  -7.89 328.28 
3.98 264.05  -8.15 328.95 
4.02 264.72  -8.16 329.62 
3.99 265.39  -8.19 330.28 
3.92 266.05  -8.47 330.95 
3.93 266.72  -8.31 331.62 
3.55 267.39  -8.1 332.28 
3.98 268.05  -8.15 332.95 
3.69 268.72  -8.1 333.62 
 
With MOF 2-21  Zeolite Y  
Absorbance Time  Absorbance Time 
2125.87 274.98  1754.36 275.04 
-5.82 275.65  579.73 275.71 
-6.49 276.32  331.84 276.38 
-6.77 276.98  217.3 277.04 
-7.14 277.65  150.15 277.71 
-7.11 278.32  107.03 278.38 
-6.9 278.98  77.5 279.04 
-7.06 279.65  55.66 279.71 
-7.17 280.32  39.35 280.38 
-7.23 280.98  26.69 281.04 
-7.14 281.65  16.7 281.71 
-7.04 282.32  8.69 282.38 
-6.97 282.98  2.17 283.04 
-7.15 283.65  -3.5 283.71 
-7.25 284.32  -7.82 284.38 
-7 284.98  -11.32 285.04 
-7.15 285.65  -14.24 285.71 
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-7.23 286.32  -17.47 286.38 
 
 
 
 
 
 
 
With MOF 2-21  
 
 
 
 
 
 
 
Zeolite Y 
Absorbance Time  Absorbance  Time 
-7.06 286.98  -20.05 287.04 
-6.99 287.65  -22.56 287.71 
-7.07 288.32  -24.59 288.38 
-7.15 288.98  -26.26 289.04 
-7.09 289.65  -28.2 289.71 
-7.2 290.32  -29.46 290.38 
-7.1 290.98  -30.97 291.04 
-7.11 291.65  -31.97 291.71 
-7.1 292.32  -32.59 292.38 
-7.14 292.98  -33.43 293.04 
-7.3 293.65  -34.38 293.71 
-7.16 294.32  -35.21 294.38 
-7.04 294.98  -36.07 295.04 
-7.12 295.65  -36.58 295.71 
-7.22 296.32  -37.6 296.38 
-7.48 296.98  -38.27 297.04 
-7.04 297.65  -38.64 297.71 
-7.18 298.32  -39.23 298.38 
-7.27 298.98  -39.85 299.04 
-7.34 299.65  -39.9 299.71 
-7.26 300.32  -40.81 300.38 
-7.09 300.98  -41.09 301.04 
-7.28 301.65  -41.49 301.71 
-7.29 302.32  -42.04 302.38 
-7.23 302.98  -42.16 303.04 
-7.42 303.65  -42.58 303.71 
-7.66 304.32  -42.81 304.38 
-7.41 304.98  -43.18 305.04 
-7.42 305.65  -43.44 305.71 
-7.58 306.32  -43.37 306.38 
-7.32 306.98  -43.77 307.04 
-7.29 307.65  -44.08 307.71 
-7.11 308.32  -44.22 308.38 
-7.3 308.98  -44.4 309.04 
-7.55 309.65  -44.62 309.71 
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-7.31 310.32  -45.07 310.38 
-7.37 310.98  -44.92 311.04 
-7.36 311.65  -45.22 311.71 
-7.45 312.32  -45.3 312.38 
-7.77 312.98  -45.46 313.04 
-7.51 313.65  -45.52 313.71 
 
With MOF 2-21  
 
 
 
 
 
 
 
 
Zeolite Y 
Absorbance Time  Absorbance Time 
-7.55 314.32  -45.84 314.38 
-7.38 314.98  -45.85 315.04 
-7.41 315.65  -45.78 315.71 
-7.38 316.32  -46.24 316.38 
-7.58 316.98  -46.34 317.04 
-7.47 317.65  -46.47 317.71 
-7.44 318.32  -46.51 318.38 
-7.51 318.98  -46.38 319.04 
-7.19 319.65  -46.66 319.71 
-7.56 320.32  -46.7 320.38 
-7.48 320.98  -46.83 321.04 
-7.68 321.65  -47.12 321.71 
-7.55 322.32  -47.04 322.38 
-7.59 322.98  -47.32 323.04 
-7.46 323.65  -47.42 323.71 
-7.56 324.32  -47.34 324.38 
-7.62 324.98  -47.37 325.04 
-7.79 325.65  -47.53 325.71 
-7.57 326.32  -47.45 326.38 
-7.67 326.98  -47.53 327.04 
-7.85 327.65  -47.53 327.71 
-7.64 328.32  -47.72 328.38 
-8 328.98  -48.07 329.04 
-7.66 329.65  -47.81 329.71 
-7.59 330.32  -47.98 330.38 
-7.64 330.98  -47.76 331.04 
-7.52 331.65  -47.97 331.71 
-7.51 332.32  -48.26 332.38 
-7.49 332.98  -48.1 333.04 
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-7.6 333.65  -48.24 333.71 
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Appendix B: Matlab Code 
 
Script 1: Residence times and dead volume for system validation 
This script takes raw data from the HPLC and solves for the dead volume of the system. This is 
done by first grabbing the HPLC data points from the desorption region and normalizing the 
concentration. The normalized concentration is plotted vs time and the slope of the initial short 
time region is found by modeling it as a first order polynomial with polyfit. This slope is used to 
find the washout time and the washout time is plotted as a function of the inverse of the flow rate 
that the data was collected at. The slope of the washout time vs inverse flow rate graph is the 
dead volume of the configuration. 
 
clc 
clear 
  
  
%Converting HPLC Data from excel file into a string 
str=["Data 1.xlsx","Data 2.xlsx","Data 3.xlsx"]; 
  
%Importing Absorbance data from the previously defined string for 
%each flow rate, q 
for i=1:3 
     
   Data=xlsread(str(i)); 
   q05(1:9101,i)= Data(10500:19600,2); 
   q1(1:9101,i)=Data(28500:37600,2); 
   q15(1:9101,i)=Data(46500:55600,2); 
   q2(1:9101,i)=Data(64500:73600,2); 
   q25(1:9101,i)=Data(82500:91600,2); 
   q3(1:9101,i)=Data(100500:109600,2);   
end 
%finding maximum absorbance values for  
%the imported data range 
for i=1:3 
   Maxq05=max(q05(:,1:i)); 
   Maxq1=max(q1(:,1:i)); 
   Maxq15=max(q15(:,1:i)); 
   Maxq2=max(q2(:,1:i)); 
   Maxq25=max(q25(:,1:i)); 
   Maxq3=max(q3(:,1:i));    
end 
  
%finding minimum absorbance values for  
%the imported data range 
for i=1:3 
   Minq05=min(q05(:,1:i)); 
   Minq1=min(q1(:,1:i)); 
   Minq15=min(q15(:,1:i)); 
   Minq2=min(q2(:,1:i)); 
   Minq25=min(q25(:,1:i)); 
   Minq3=min(q3(:,1:i)); 
     
end 
  
%Normalizing concentration and taking  
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%the natural log of the normalized concentration 
for i=1:3 
  b05=q05(:,1:i)-Minq05(1,1:i); 
  b1=q1(:,1:i)-Minq1(1,1:i); 
  b15=q15(:,1:i)-Minq15(1,1:i); 
  b2=q2(:,1:i)-Minq2(1,1:i); 
  b25=q25(:,1:i)-Minq25(1,1:i); 
  b3=q3(:,1:i)-Minq3(1,1:i); 
  c05=b05./(Maxq05(1,1:i)-Minq05(1,1:i)); 
  c1=b1./(Maxq1(1,1:i)-Minq1(1,1:i)); 
  c15=b15./(Maxq15(1,1:i)-Minq15(1,1:i)); 
  c2=b2./(Maxq2(1,1:i)-Minq2(1,1:i)); 
  c25=b25./(Maxq25(1,1:i)-Minq25(1,1:i)); 
  c3=b3./(Maxq3(1,1:i)-Minq3(1,1:i)); 
  logc05=log10(c05(:,1:i)); 
  logc1=log10(c1(:,1:i)); 
  logc15=log10(c15(:,1:i)); 
  logc2=log10(c2(:,1:i)); 
  logc25=log10(c25(:,1:i)); 
  logc3=log10(c3(:,1:i)); 
end 
  
%Defining time ranges for plotting 
tt=Data(1600:10700,1); 
tt1=Data(10800:19900,1); 
tt2=Data(20000:29100,1); 
tmin=min(tt); 
tmin1=min(tt1); 
tmin2=min(tt2); 
tnorm=tt-tmin; 
tnorm1=tt1-tmin1; 
tnorm2=tt2-tmin2; 
tnorm3=tnorm1(1:9101,1); 
  
%figures 1 through 6 plot normalized concentration vs time 
%for each flow rate 
figure(1) 
plot(tnorm,logc05(:,1)) 
xlabel('Normalized time,min') 
ylabel('ln(C/Co)') 
title('Configuration Comparison 0.5/min') 
  
hold on 
x2=logc05(:,2); 
plot(tnorm,x2) 
x3=logc05(:,3); 
plot(tnorm,x3) 
legend('Full','Pump2DAD','ValveSwitching') 
hold off 
  
figure(2) 
plot(tnorm1,logc1(:,1)) 
xlabel('time,min') 
ylabel('Normalized concentration') 
title('Configuration Comparison 1ml/min') 
hold on 
x5=logc1(:,2); 
plot(tnorm1,x5) 
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x6=logc1(:,3); 
plot(tnorm1,x6) 
legend('Full','Pump2DAD','ValveSwitching') 
hold off 
  
figure(3) 
plot(tnorm1,logc15(:,1)) 
xlabel('time,min') 
ylabel('Normalized concentration') 
title('Configuration Comparison 1.5ml/min') 
hold on 
x8=logc15(:,2); 
plot(tnorm1,x8) 
x9=logc15(:,3); 
plot(tnorm1,x9) 
legend('Full','Pump2DAD','ValveSwitching') 
hold off 
  
figure(4) 
plot(tnorm1,logc2(:,1)) 
xlabel('time,min') 
ylabel('Normalized concentration') 
title('Configuration Comparison 2ml/min') 
hold on 
x11=logc2(:,2); 
x12=logc2(:,3); 
plot(tnorm1,x11) 
plot(tnorm1,x12) 
legend('Full','Pump2DAD','ValveSwitching') 
hold off 
  
figure(5) 
plot(tnorm1,logc25(:,1)) 
xlabel('time,min') 
ylabel('Normalized concentration') 
title('Configuration Comparison 2.5ml/min') 
hold on 
x13=logc25(:,2); 
x14=logc25(:,3); 
plot(tnorm1,x13) 
plot(tnorm1,x14) 
legend('Full','Pump2DAD','ValveSwitching') 
hold off 
  
figure(6) 
plot(tnorm1,logc3(:,1)) 
xlabel('time,min') 
ylabel('Normalized concentration') 
title('Configuration Comparison 3ml/min') 
hold on 
x15=logc3(:,2); 
x16=logc3(:,3); 
plot(tnorm1,x15) 
plot(tnorm1,x16) 
legend('Full','Pump2DAD','ValveSwitching') 
hold off 
  
%Indexing to determine the linear short time region 
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%for plotting and solving for residence time 
[~,index1]=min((tnorm-0.8).^2);   
[~,index2]=min((tnorm-0.9).^2);                             
[~,index3]=min((tnorm1-2.7).^2); 
[~,index4]=min((tnorm1-2.8).^2); 
[~,index5]=min((tnorm2-2.7).^2); 
[~,index6]=min((tnorm2-2.8).^2); 
[~,index7]=min((tnorm-0.4).^2); 
[~,index8]=min((tnorm-0.46).^2); 
[~,index9]=min((tnorm-1.86).^2); 
[~,index10]=min((tnorm-1.88).^2); 
[~,index11]=min((tnorm-1.74).^2); 
[~,index12]=min((tnorm-1.75).^2); 
[~,index13]=min((tnorm-0.27).^2); 
[~,index14]=min((tnorm-0.28).^2); 
[~,index15]=min((tnorm-1.3).^2); 
[~,index16]=min((tnorm-1.32).^2); 
[~,index17]=min((tnorm-1.3).^2); 
[~,index18]=min((tnorm-1.4).^2); 
[~,index19]=min((tnorm-0.19).^2); 
[~,index20]=min((tnorm-0.2).^2); 
[~,index21]=min((tnorm-0.9).^2); 
[~,index22]=min((tnorm-0.92).^2); 
[~,index23]=min((tnorm-0.87).^2); 
[~,index24]=min((tnorm-0.88).^2); 
[~,index25]=min((tnorm-0.17).^2); 
[~,index26]=min((tnorm-0.19).^2); 
[~,index27]=min((tnorm-0.544).^2); 
[~,index28]=min((tnorm-0.556).^2); 
[~,index29]=min((tnorm-0.515).^2); 
[~,index30]=min((tnorm-0.535).^2); 
[~,index31]=min((tnorm-0.13).^2); 
[~,index32]=min((tnorm-0.14).^2); 
[~,index33]=min((tnorm-0.14).^2); 
[~,index34]=min((tnorm-0.168).^2); 
[~,index35]=min((tnorm-0.14).^2); 
[~,index36]=min((tnorm-0.16).^2); 
  
%Solving for residence time using the previous indexes of the  
%short time region by using polyfit for a first order polynomial 
%to find the slope which is related to residence time 
  
%Flowrate of 0.5ml/min (Order: 'Full', 'Pump2DAD', 'ValveSwitching') 
taui1=polyfit(tnorm(index1:index2),logc05(index1:index2,1),1); 
tau1=(-1/taui1(1,1))*60; 
taui2=polyfit(tnorm(index3:index4),x2(index3:index4),1); 
tau2=(-1/taui2(1,1))*60; 
taui3=polyfit(tnorm(index5:index6),x3(index5:index6),1); 
tau3=(-1/taui3(1,1))*60; 
  
%Flowrate of 1ml/min (Order: 'Full','Pump2DAD','ValveSwitching') 
taui4=polyfit(tnorm(index7:index8),logc1(index7:index8,1),1); 
tau4=(-1/taui4(1,1))*60; 
taui5=polyfit(tnorm1(index9:index10),x5(index9:index10),1); 
tau5=(-1/taui5(1,1))*60; 
taui6=polyfit(tnorm1(index11:index12),x6(index11:index12),1); 
tau6=(-1/taui6(1,1))*60; 
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%Flowrate of 1.5ml/min (Order: 'Full','Pump2DAD','ValveSwitching') 
taui7=polyfit(tnorm1(index13:index14),logc15(index13:index14,1),1); 
tau7=(-1/taui7(1,1))*60; 
taui8=polyfit(tnorm1(index15:index16),x8(index15:index16),1); 
tau8=(-1/taui8(1,1))*60; 
taui9=polyfit(tnorm1(index17:index18),x9(index17:index18),1); 
tau9=(-1/taui9(1,1))*60; 
  
%Flowrate of 2ml/min ('Full','Pump2DAD','ValveSwitching') 
taui10=polyfit(tnorm(index19:index20),logc2(index19:index20,1),1); 
tau10=(-1/taui10(1,1))*60; 
taui11=polyfit(tnorm(index21:index22),x11(index21:index22),1);  
tau11=(-1/taui11(1,1))*60; 
taui12=polyfit(tnorm1(index23:index24),x12(index23:index24),1);  
tau12=(-1/taui12(1,1))*60; 
  
%Flowrate of 2.5ml/min ('Full','Pump2DAD','ValveSwitching') 
taui13=polyfit(tnorm(index25:index26),logc25(index25:index26,1),1); 
tau13=(-1/taui13(1,1))*60; 
taui14=polyfit(tnorm(index27:index28),x13(index27:index28),1);  
tau14=(-1/taui14(1,1))*60; 
taui15=polyfit(tnorm1(index29:index30),x14(index29:index30),1); 
tau15=(-1/taui15(1,1))*60; 
  
%Flowrate of 3ml/min ('Full','Pump2DAD','ValveSwitching') 
taui16=polyfit(tnorm(index31:index32),logc3(index31:index32,1),1); 
tau16=(-1/taui16(1,1))*60; 
taui17=polyfit(tnorm(index33:index34),x15(index33:index34),1); 
tau17=(-1/taui17(1,1))*60; 
taui18=polyfit(tnorm1(index35:index36),x16(index35:index36),1); 
tau18=(-1/taui18(1,1))*60; 
  
  
%Defining flow rates, ml/min 
f=0.5; 
f1=1; 
f2=1.5; 
f3=2; 
f4=2.5; 
f5=3; 
  
%changing flow rates to inverse flow rate in units 
%of sec/ml 
fa=(1/f)*60; 
f1a=(1/f1)*60; 
f2a=(1/f2)*60; 
f3a=(1/f3)*60; 
f4a=(1/f4)*60; 
f5a=(1/f5)*60; 
  
%Organizing Residence time of each flow rate into matrices 
%for each configuration 
  
%Order: Pump2dad, Novalve, Noinject,Full 
y=[tau1 tau4 tau7 tau10 tau13 tau16 0]; 
y1=[tau2 tau5 tau8 tau11 tau14 tau17 0]; 
y2=[tau3 tau6 tau9 tau12 tau15 tau18 0]; 
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%Creating a matrix of inverse flow rates 
z=[fa f1a f2a f3a f4a f5a 0]; 
  
%Plotting only the linear short time region based on  
%indexed values to check for accuracy in figures 
%7 through 12 
figure(7) 
plot(tnorm(index1:index2),logc05(index1:index2,1),'-O') 
xlabel('time,min') 
ylabel('log10(C/Co)') 
title('Config Compare 0.5ml/min') 
hold on 
plot(tnorm(index3:index4),x2(index3:index4),'-^') 
plot(tnorm(index5:index6),x3(index5:index6),'-x') 
legend('Full', 'Pump2DAD','ValveSwitch') 
hold off 
  
figure(8) 
plot(tnorm1(index7:index8),logc1(index7:index8),'-O') 
xlabel('time,min') 
ylabel('log10(C/Co)') 
title('Config Compare 1ml/min') 
  
hold on 
  
plot(tnorm1(index9:index10),x5(index9:index10),'-^') 
plot(tnorm1(index11:index12),x6(index11:index12),'-x') 
legend('Full', 'Pump2DAD','ValveSwitch') 
hold off 
  
figure(9) 
plot(tnorm1(index13:index14),logc15(index13:index14),'-O') 
xlabel('time,min') 
ylabel('log10(C/Co)') 
title('Config Compare 1.5ml/min') 
  
hold on 
plot(tnorm2(index15:index16),x8(index15:index16),'-^') 
plot(tnorm2(index17:index18),x9(index17:index18),'-x') 
legend('Full', 'Pump2DAD','ValveSwitch') 
hold off 
  
figure(10) 
plot(tnorm1(index19:index20),logc2(index19:index20,1),'-O') 
xlabel('time,min') 
ylabel('log10(C/Co)') 
title('Config Compare 2ml/min') 
hold on 
plot(tnorm1(index21:index22),x11(index21:index22),'-^') 
plot(tnorm1(index23:index24),x12(index23:index24),'-x') 
legend('Full', 'Pump2DAD','ValveSwitch') 
hold off 
  
figure(11) 
plot(tnorm1(index25:index26),logc25(index25:index26,1),'-O') 
xlabel('time,min') 
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ylabel('log10(C/Co)') 
title('Config Compare 2.5ml/min') 
hold on 
plot(tnorm1(index27:index28),x13(index27:index28),'-^') 
plot(tnorm1(index29:index30),x14(index29:index30),'-x') 
legend('Full', 'Pump2DAD','ValveSwitch') 
hold off 
  
figure(12) 
plot(tnorm2(index31:index32),logc3(index31:index32,1),'-O') 
xlabel('time,min') 
ylabel('log10(C/Co)') 
title('Config Compare 3ml/min') 
hold on 
plot(tnorm2(index33:index34),x15(index33:index34),'-^') 
plot(tnorm2(index35:index36),x16(index35:index36),'-x') 
legend('Full', 'Pump2DAD','ValveSwitch') 
hold off 
  
%plot of residence time vs inverse flow rate 
%and using polyfit for a first order polynomial  
%to find slope aka dead volume 
figure(13) 
plot(z,y,'-O') %Full 
xlabel('inverse flow rate, (seconds/mL)') 
ylabel('Residence time, tau (seconds)') 
title('Configuration Comparison 6 flows') 
hold on 
plot(z,y1,'-^') %Pump2dad 
plot(z,y2,'-x') %valveswitch 
legend('Full', 'Pump2DAD','ValveSwitch') 
hold off 
  
  
%v symbolizes dead volume which is solved by dividing inverse flow rate  
%by residence times using the least squares method 
%Lower 3 flows 
v=z(:)\y(:); 
v1=z(:)\y1(:); 
v2=z(:)\y2(:); 
  
%putting dead volumes for each configuration in a vector  
%for graphing purposes 
vall=[v(1,1) v1(1,1) v2(1,1)]; 
vall1=[v1(1,1) v2(1,1)]; 
  
%Bar graphs for dead volume at different configurations 
figure(15) 
name={'Full';'Pump2DAD';'ValveSwitch'}; 
bar(vall) 
ylabel('Dead Volume, ml') 
set(gca,'xticklabel',name) 
title('Dead Volume Graph') 
  
  
%Checking accuracy of polyfit for index to ensure 
%the region used for residence time is accurately modeled using  
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%polyfit 
figure(16) 
plot(tnorm1,x14) 
xlabel('time,min') 
ylabel('ln(C/Co)') 
title('2.5 ml/min ValveSwitch') 
axis([0 6 -6 0.1]) 
taufit=taui15(1,1)*tnorm1+taui15(1,2); 
hold on 
plot(tnorm1,taufit) 
legend('Actual','Polyfit') 
hold off 
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Script 2: Numerical_PDE_MAIN.m 
 
This script evaluates the overall mass balance based on initial guesses for parameters like 
diffusion and flow rate. The diffusion coefficient guess, initial concentration vector, time vector, 
and flow rates are defined in this script. The concentration of paracetamol as a function of radius 
and concentration in the mobile liquid phase from desorption are both plotted and parameters are 
changed until the HPLC data is accurately represented by the model. The parameters definied in 
bvpscripts.m are referenced here. 
 
function res = Numerical_PDE_MAIN(param, t, thetaexp, plotson) 
    % Purpose of this code is to evaluate unsteady dispersion model for  
    % a step input PBR 
    %Inputs 
        %param = [L log10D] 
        %t = time vector 
        %thetaexp = experimental data of length t 
        %plotson = 1 for displaying all plots, 0 for displaying only fit 
         
    %Outputs 
        %res = Error to be minimized for fit 
     
    %% Inputs 
    Dab     = 10^param(2); %m^2/s   change time scale and/or time steps when 
changing Dab 
    L       = param(1);    %Fitting parameter defined by Brandani & Ruthven 
(1995) 
    ntau    = length(t);   % Increments in tau 
    tauf    = t(end);      % Final value for tau % s 
    nx      = 150;         % Increments in x % 
  
    % Initial Condition 
    theta0 = ones(nx+1,1); % % Initial concentration profile 
  
    %% Define Variables 
  
    % Discritize Variables 
    tau     =   linspace(0,tauf,ntau); 
    x       =   linspace(1e-10,7e-6,nx+1); % 14 um particle 
    theta   =   ones(nx+1,ntau); 
    theta(:,1) =    theta0; 
  
    %% Solve PDE 
     
    y0 = ones(size(theta0))*0.001; 
     
    for i = 2:ntau                  %Solving PDE from initial t to final t, 
stepping through each sequential time step 
        dtau = tau(i)-tau(i-1); 
            if mod(i,10) == 0 
            disp(['Status: ', num2str(i-1), ' of ', num2str(ntau-1)]) 
            end 
        y0 = theta(:,i-1); 
        y = bvpscripts(Dab,y0,x,dtau,L); 
        theta(1:end,i) = y; 
    end 
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    res = (log(theta(end-1,:)) - log(thetaexp')).^2;        %Error between 
experimental data and model being minimized by ZLC_Fits 
  
     
  
    %% Plots 
     
    figure(1) 
    hold on 
    semilogy(t,thetaexp,'b-',t,theta(end-1,:),'-') 
    set(gca,'YScale','log') 
    title(['X = ' num2str(param)]) 
    drawnow 
    hold off 
     
    if plotson == 1 
        figure(2); 
        plot(x,theta(1:end,:)) 
        xlabel('r, [m]') 
        ylabel('\theta = C/C_0, [ - ]') 
  
        figure(3); 
        surf(tau,x,theta) 
        xlabel('time, [s]') 
        ylabel('r, [m]') 
        zlabel('\theta = C/C_0, [ - ]') 
  
        figure(4); 
        plot(tau,theta(1,:),tau,theta(end,:)) 
        legend('Center','Surface') 
        xlabel('time, [s]') 
        ylabel('\theta = C/C_0, [ - ]') 
    end 
end 
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Script 3: bvpscripts.m 
 
This script is used to define and solve the boundary conditions for solving the mass balance 
equation for the ZLC.  The overall mass balance equation is defined as well. This is soldved 
simultaneously with the numerical pde script to model the HPLC data. 
 
function res = Numerical_PDE_MAIN(param, t, thetaexp, plotson) 
    % Purpose of this code is to evaluate unsteady dispersion model for  
    % a step input PBR 
    %Inputs 
        %param = [L log10D] 
        %t = time vector 
        %thetaexp = experimental data of length t 
        %plotson = 1 for displaying all plots, 0 for displaying only fit 
         
    %Outputs 
        %res = Error to be minimized for fit 
     
    %% Inputs 
    Dab     = 10^param(2); %m^2/s   change time scale and/or time steps when 
changing Dab 
    L       = param(1);    %Fitting parameter defined by Brandani & Ruthven 
(1995) 
    ntau    = length(t);   % Increments in tau 
    tauf    = t(end);      % Final value for tau % s 
    nx      = 150;         % Increments in x % 
  
    % Initial Condition 
    theta0 = ones(nx+1,1); % % Initial concentration profile 
  
    %% Define Variables 
  
    % Discritize Variables 
    tau     =   linspace(0,tauf,ntau); 
    x       =   linspace(1e-10,7e-6,nx+1); % 14 um particle 
    theta   =   ones(nx+1,ntau); 
    theta(:,1) =    theta0; 
  
    %% Solve PDE 
     
    y0 = ones(size(theta0))*0.001; 
     
    for i = 2:ntau                  %Solving PDE from initial t to final t, 
stepping through each sequential time step 
        dtau = tau(i)-tau(i-1); 
            if mod(i,10) == 0 
            disp(['Status: ', num2str(i-1), ' of ', num2str(ntau-1)]) 
            end 
        y0 = theta(:,i-1); 
        y = bvpscripts(Dab,y0,x,dtau,L); 
        theta(1:end,i) = y; 
    end 
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    res = (log(theta(end-1,:)) - log(thetaexp')).^2;        %Error between 
experimental data and model being minimized by ZLC_Fits 
  
     
  
    %% Plots 
     
    figure(1) 
    hold on 
    semilogy(t,thetaexp,'b-',t,theta(end-1,:),'-') 
    set(gca,'YScale','log') 
    title(['X = ' num2str(param)]) 
    drawnow 
    hold off 
     
    if plotson == 1 
        figure(2); 
        plot(x,theta(1:end,:)) 
        xlabel('r, [m]') 
        ylabel('\theta = C/C_0, [ - ]') 
  
        figure(3); 
        surf(tau,x,theta) 
        xlabel('time, [s]') 
        ylabel('r, [m]') 
        zlabel('\theta = C/C_0, [ - ]') 
  
        figure(4); 
        plot(tau,theta(1,:),tau,theta(end,:)) 
        legend('Center','Surface') 
        xlabel('time, [s]') 
        ylabel('\theta = C/C_0, [ - ]') 
    end 
end 
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Script 4: ZLC_Fits.m 
 
%% ZLC Analysis 
  
%The purpose of this code is to iterate through a number of guesses to 
%attempt to converge to a PDE model that matches the given experimental 
%data 
  
close all 
clear 
clc 
  
%% Inputs 
    %Normalized desorption profile 
    thetadata = downsample(dlmread('NaTrial2.csv'), 20); %Downsampling to 
every 20th row 
    t = thetadata(1:301,1);         %time column 
    thetaexp = thetadata(1:301,2);  %normalized concentration column 
  
%% Guesses 
    log10D = -12.15; %log10(diffusion constant)  
    L0 = 200; % dimesnionless, 1 - 10000 (bigger = better) 
  
     
%% Parse Input Data 
    x0 = [L0 log10D]; 
  
%% Fit ZLC      
[x, error] = lsqnonlin(@Numerical_PDE_MAIN,x0,[175 -13],[10000 -12],[ ], t, 
thetaexp, 0);  %Iterative solution based on non linear least squares fit 
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Appendix C: SDS Sheets 
 
Sodium Nitrate 
https://beta-
static.fishersci.com/content/dam/fishersci/en_US/documents/programs/education/regulatory-
documents/sds/chemicals/chemicals-s/S25558B.pdf 
 
Terephthalic Acid 
https://www.fishersci.com/shop/msdsproxy?productName=AC321440010&productDescription=
TEREPHTHALIC-D4+ACID%2C+1G&catNo=AC32144-
0010&vendorId=VN00032119&storeId=10652 
 
Zeolite Y and Na-Y 
https://www.fishersci.com/store/msds?partNumber=AA4586214&productDescription=ZEOLIT
E+Y%2C+SODIUM+25G&vendorId=VN00024248&countryCode=US&language=en 
 
Zinc Nitrate Hexahydrate 
https://www.fishersci.com/shop/msdsproxy?productName=Z45500&productDescription=ZINC+
NITRATE+CRYSTAL+CERT+500G&catNo=Z45-
500&vendorId=VN00033897&storeId=10652 
 
Diethylformamide 
https://www.fishersci.com/shop/msdsproxy?productName=AC181370250&productDescription=
N%2CN-
DIETHYLFORMAMIDE%2C+99+25ML&catNo=AC181370250&vendorId=VN00032119&st
oreId=null 
 
 
  
  
 
 
 
